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Abstract  
 
Synthesis and optimization of novel diamides using the Ugi reaction for  
 anti-malarial screening 
 
Khalid Baig S Mirza, 
 
Jean-Claude Bradley, Ph.D. 
 
The primary goal of this work was to easily synthesize a library of diamides predicted to be 
potential anti-malarial agents. This thesis focuses on synthesis of those diamides by the Ugi 
reaction and further optimization studies.  Solubility of the reactants and the Ugi product has 
been used to optimize the reaction. During the preliminary phase we focused on the synthesis of 
a library of active compounds obtained from Find-A-Drug, a non-profit computing project which 
serves to address a number of diseases. Although we were unable to synthesize any of the 
compounds from the Find-A-Drug library, the diamide nucleus served as ‘pharmacophore’ for 
the later libraries that were develop in collaboration with computational chemists. 
Some of the diamides synthesized showed promising results when tested for bio-activity against 
the plasmodium enzyme, falcipain-2. 
However, during the synthetic process of these diamides via the Ugi reaction it became clear that 
not every compound from the library could be synthesized by one general method. One major 
issues encountered was related to solubility of starting materials in methanol, the usual choice of 
solvent used for the Ugi reaction. Therefore, optimization studies were carried out to estimate the 
best solvent and conditions required in order to obtain a better yield with crystalline product, 
which would not require further chromatographic purification.  
In one of the optimization studies involving benzaldehyde, furfurylamine, boc-glycine and tert-
butylisocyanide best results in terms of yield were obtained when the reaction was performed at 
 vi 
0.4M concentration per component in methanol with 1.2eq imine. This was a significant 
improvement compared to the reaction performed under equimolar conditions with a 49% yield. 
Apart from solubility, reaction kinetics and solvent effects which played major role in the final 
yield of the reaction were also studied. 
In essence we postulate that knowing the kinetics and ‘by being able to predict the solubility of 
starting materials and products, one can predict the optimal solvent and concentration to carry 
out the reaction and isolate the Ugi product by simple filtration.’  
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CHAPTER 1: INTRODUCTION & OVERVIEW 
 
Scientific research conducted in the open using internet tools which are available freely is 
commonly related to as Open Science. “Open Notebook Science” coined by Prof. Jean-
Claude Bradley of Drexel University, is a term used to indicate that the primary record of 
a research in its entirety is made public over the internet as soon as it is conducted1
 
. This 
includes the planned experimental procedure, the log, raw data, and a discussion of the 
analysis of the data, the assumptions and the conclusions drawn from the specific 
experiment and the project in general.  
There are two obvious objectives of Open Notebook Science, a) to achieve and advocate 
complete transparency of research being performed2 b) to serve an open invitation to 
collaborate with like minded researchers / scientists who are capable and willing to 
participate in the project3. Advantages of an open notebook become apparent when one 
considers the reliability of the data and the collaborative results of the project4
 
.  
The concept of Open Notebook Science was extended to the malaria project and was 
christened as the UsefulChem project. Then UsefulChem project can be described as a 
real time collaborative effort between organic chemists, cheminformatics specialists, 
mathematicians and of course the bio-medical scientists to develop an inexpensive 
treatment for malaria5. 
2 
 
This chapter is aimed at outlining the details of the UsefulChem project. The second part 
of this chapter provides an overview of the thesis and puts in to perspective the concept 
of Open Notebook Science. 
 
1.1 The UsefulChem Project 
As mentioned earlier the primary objective of the UsefulChem project was to synthesize 
an inexpensive and viable treatment/cure for malaria using the Ugi reaction. The Ugi 
reaction is a four component one pot reaction in methanol. It is a reaction involving an 
aldehyde, an amine, a carboxylic acid and an isocyanide6. The Ugi product, a diamide, 
precipitates out at room temperature usually with in twenty four hours.  The facile nature 
of the Ugi reaction makes it very useful in synthesizing large libraries of a compound of 
diverse structures7
 
. However not all of the Ugi reaction performed yield solid products. 
This was important because, a solid product could be easily isolated by washing and 
recrystallization, removing an expensive chromatographic purification step.  
Therefore in order to make the library synthesis viable, a precipitation model had to be 
constructed8
 
. This model would predict the combination of starting materials which 
would form a solid product from the Ugi reaction. The modeling studies required the 
expertise of a Cheminformatics scientist.  
Freely available tools were used for the UsefulChem project.  Wikispaces served as the 
primary lab notebook.  A new page was created for each experiment performed. Any 
pictures or video recording obtained during an experiment was uploaded directly on the 
3 
 
wiki and on You Tube for easy access. Google Spreadsheets were used for data 
processing and calculations. A web-browser based java application called JSpecView9
 
 
was used to view and process spectra obtained. All NMR, IR and UV-VIS spectra 
obtained from the instruments were viewable by JSpecView, open source software 
written and developed by Prof. Lancashire of University of the West Indies, at Kingston, 
Jamaica. 
The online nature of the project using the UsefulChem blog and the UsefulChem wiki 
attracted Dr. Rajarshi Guha of Indiana University, who with further improvements from 
Prof. Andrew Lang of Oral Roberts University constructed a working model. This model 
not only predicts the Ugi reactants which are more likely to form a solid product from a 
reaction in methanol but also in other solvents. Construction of the model required 
solubility measurements of the starting materials and the products of the Ugi reaction in 
different solvents. Different methods were used to measure solubility including UV-VIS, 
SpeedVac method and the NMR method. However, a Semi-Automated Measurement of 
Solubility (SAMS) method based on NMR was selected as the method of choice for the 
assessments10
 
.  
Compounds synthesized by the Ugi reaction were tested against falcipain-2, a papain 
family cystein protease inhibitor used by the malarial parasite, Plasmodium falciparum to 
degrade erythrocytic proteins especially hemoglobin. Tests results screened several of the 
synthesized Ugi products to be active against the enzyme. These were compounds from 
the virtual libraries that were predicted to be active.11. 
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Although several Ugi products showed activity towards a key enzyme of the malarial 
parasite, several other studies have to be conducted before any of the compounds could 
be identified as a drug candidate. 
 
1.2 Overview and Organization of the thesis 
 
The general focus of the thesis is on the synthesis of a library of anti-malarial agents 
using the Ugi reaction through an Open Notebook Science approach. 
 
Chapter 2 provides a justification for the Open Notebook Science approach and its 
importance. This chapter aims at impressing the importance of a transparent system for 
the scientific discourse12. The chapter describes the failed experimental details of the 
oxidation of benzylic alcohols to ketones using Sodium hydride, which appeared in the 
Journal of American Chemical Society13
 
.  
Chapter 3 describes the initial course of the research directed towards the synthesis of  
3,4-dihydrophenyl acetaldehyde (DOPAL) which formed a part the Ugi reaction used for 
the synthesis of a virtual library of 1,4-diketopiperazines predicted to be active against 
enoyl-reductase, a key enzyme in the biochemical pathway required for cell wall 
synthesis of the malarial parasite14
 
. 
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Chapter 4 includes a discussion of the initial Ugi reaction attempts and the anatomy of 
the Ugi reaction based on its mechanism. The first step of the reaction, the imine 
formation was monitored using proton NMR studies. Solvent effect on the rate of imine 
formation is also included in this chapter. Imine kinetics using free Java based software, 
called JSpecView was performed15
 
.  
Chapter 5 focuses on furfuryl cleavage. A reterosynthetic analysis of the 1,4 –
diketopiperazines virtual library designed as potential enoyl reductase inhibitors, required 
the Ugi reaction followed by a transamidation type cyclization in 10% TFA in 1,2-
dichlorethane. The Ugi products synthesized contained 5-methyl furfuryl group on 
tertiary amide nitrogen16
 
.  When these Ugi products were subjected to the cyclization 
protocol, they underwent a 1,6-methylfurfuryl elimination, defined as the “Furfuryl 
Cleavage”. No description of such behavior of similar compounds has been found in the 
literature. A mechanism has been proposed for the cleavage along with some kinetic 
studies.  
 Chapter 6 describes the optimization of reaction conditions for the Ugi reaction of 
benzaldehyde, furfurylamine, boc-glycine and tert-butyl isocyanide using automated 
liquid handler and a 48 slot Mettler-Toledo MiniBlock®.  Effect of solvent composition, 
effect of reactant concentration and effect of the excess of certain reagents are included17
 
. 
 Chapter 7 contains the synthetic details of about six hundred Ugi reactions performed. 
Approximately 13% of the reactions performed yielded a solid Ugi product. Trends 
6 
 
observed in terms of the reaction conditions and the reactants which likely cause 
precipitation of the product is included in this chapter. Insufficient solubility of 
polyaromatic starting materials in the solvents in the Ugi reactions was a primary reason 
for an unsuccessful reaction attempt, solubility issues of few polyaromatic starting 
materials and the Ugi products are discussed here. A few other likely causes for the 
failure of the Ugi product precipitation are also discussed here. 
 
Chapter 8 focuses on the solubility measurements of the chemicals involved in the Ugi 
reaction. The measurements contributed towards the construction of an empirical 
solubility prediction model, aimed primarily at predicting the likelihood of selective 
precipitation of a product from the Ugi reaction. Methods used for solubility assessment 
and their reliability are discussed in this chapter18
 
.  
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Chapter: 2 
 
Oxidation by sodium hydride and Social networking  
 
 
2.1 Introduction 
 
Traditionally sodium hydride has been used as a base1 in the formation of an enolate ion and its 
subsequent reactions. It has been some times also used as a reducing agent, for example in the 
reduction of benzophenone to benzhydrol in boiling xylene2
 
. It has also been used in the 
reduction of enolizable ketones as well. Reduction of norcamphor and 5-norbornen-2-one with 
sodium hydride was reported by McConaghy Jr. and Bloomfield. The ketones were reduced by 
refluxing sodium hydride and methyl iodide in glyme. 
Fig 2.1 – Though not very common, reductions by NaH are known.  McConaghy Jr. and 
Bloomfield reported the reduction of norcamphor followed by ether formation using methyl 
iodide3.  Scheme adapted from McConaghy Jr. J. S., Bloomfield, J. J.; J. Org. Chem; 33, 9; 3425-
3428 (1968). 
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Fig 2.2 – Reduction of 5-norbonen-2-one with NaH, reported in the same paper 
 
 
 
 
In essence sodium hydride has found an important place in an organic chemist’s cabinet 
primarily as a base and to a lesser extent as reducing agent. However its use as an oxidizing 
agent in a recent publication proved controversial. This chapter intends to provide an open and 
transparent investigation in to one of the reported ‘oxidations’, thereby reiterating the importance 
of an open, data centric and transparent approach to the process of scientific research which is 
seldom found in a closed type current peer reviewed corporate publication style. 
 
In July 2009 Wang et al. in JACS reported sodium hydride as being an oxidizing reagent.  They 
claim that secondary alcohols of benzylic systems under go oxidation when treated with NaH 
(2eq) in THF at room temperature. They provide an exhaustive list of secondary alcohols 
oxidized to corresponding ketones with impressive yields4
 
. 
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Fig 2.1 – Secondary alcohols (benzylic and similar) oxidized by Wang’s group to corresponding 
ketones using NaH in THF at room temperature, published in JACS 
.  
 
Following its publication in JACS, there was uproar in the synthetic blogging community 
questioning the review process of the prestigious journal. Some of the organic chemistry 
bloggers took it on to themselves to verify the claim of the publication5,6,7.  
12 
 
Professor Bradley8
This chapter details the experimental of ‘oxidation’ of one the secondary alcohol, (±)-1-
phenylethanol to the acetophenone reported in the paper.  
 suggested I repeat the process in order to verify the claims as well.  
 
2.2 Experimental 
 
Sodium hydride was added to a stirred THF solution of (±)-1-phenylethanol at 0oC. After stirring 
for 12min the ice bath was removed and the mixture was allowed to warm to room temperature. 
Aliquots were removed over the course of the reaction, and proton NMRs were taken after 
adding benzene-d6 without quenching. After 19 hours of running the reaction, it was quenched 
with ammonium chloride (saturated solution in water), extracted in ethyl acetate and dried over 
anhydrous magnesium sulfate. The dry extract was then concentrated on a high vacuum pump 
and the product was analyzed by HNMR and IR9
 
.  
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2.3 Results and discussion 
 
The reaction was monitored by taking aliquots of the solution then adding benzene-d6 to lock 
during NMR acquisition without quenching the reaction. After 19 hours at room temperature 
there was no change in the spectra, except for loss of the alcoholic proton. Acetophenone would 
have been easily detected at 7.9 and 2.6 ppm 
In a comment on Carbon-Based Curiosities, European Chemist points to a 1965 paper where 
oxidants on the surface of NaH are likely responsible for oxidative behavior (Lewis JOC10). This 
would certainly explain why some researchers are reporting some oxidation products but with 
widely divergent yields. For example, Totally Synthetic reported a 15% NMR yield for the 
conversion of the 4-chloro derivative to the corresponding ketone while Wang isolated the 
product in 86% yield. 
 
As many have pointed out, this is a very good example of the way Web2.0 tools and the 
scientific community can complement traditional publication style to move science forward.  
14 
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Figure 2.3 – No significant changes were observed in the aromatic region. 
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Chapter 3: DOPAL Synthesis 
3.1 Introduction 
Plasmodium falciparum, a unicellular protozoan is one of the causative parasites of common 
tropical malaria. The disease infects up to 500 million people in the world annually. Malaria is 
also reported to be the reason of up to three million human deaths annually, majority of who are 
children from sub-Saharan Africa.  Quinine, chloroquine, proguanil, etc were the primary drugs 
used to treat malaria until the 1950s. However drug resistance to malaria has been reported to be 
rampant. Drug resistance of Plasmodium falciparum to Chloroquine, a 4-aminoquinoline 
appeared with in twelve years of its introduction. Indeed some Plasmodium falciparum strains 
have been shown to be resistant to all known drugs currently used to treat malaria1
 
. Therefore 
there is an urgent need to develop novel anti-malarial agents targeting the biochemistry of new 
metabolic pathways.  
3.2 Enoyl Reductase inhibition 
Isoniazide is a widely used drug to treat tuberculosis. The mechanism of its action targeting 
Enoyl-acyl carrier protein reductase (InhA) works through a covalent attachment of the active 
form of the drug to the nicotinamide ring of NAD bound to the active site of the enzyme InhA. 
The same enzyme is also used in the type II fatty acid synthase system of Plasmodium (Figure 
3.1). Therefore the Enoyl-acyl carrier protein reductase (PfENR) was the target of a library of two 
hundred twenty diketopiperazines obtained from Find-a-Drug, a non-profit organization which 
works towards finding new molecules designed to target specific proteins / enzymes in order to 
treat tropical diseases like malaria, tuberculosis etc2. 
 19 
The library was designed to inhibit enyol-reductase of plasmodium species, with the docking 
studies performed using the Think software.  
Enoyl acyl carrier protein reductase (ENR or FabI) catalyzes the final step of fatty acid 
elongation cycle, which is the NADH/NADPH-dependent reduction of α, β- olefinic unsaturation 
of the fatty acids bound to acyl carrier protein3. Therefore ENR plays a major role in the fatty 
acid synthesis4
 
. 
3.3 Riboneucleotide reductase (RNR) inhibition 
Ribonucleotides are reduced to deoxyribonucelotides by Riboneucleotide reductase (RNR) 
catalyses. This is the first and rate limiting step of a denovo synthesis of 2′ - 
deoxyribonucleoside-5′-triphosphates. This ubiquitous enzyme plays a central role in DNA 
metabolism. Hence it has been an important target in the chemotherapy of malaria5
Polyhydroxyphenyl compounds are known to inhibit RNR. It is assumed that the metal-chelating 
capacity of these compounds with Fe+3 of the enzyme plays a role in its inhibition. However 
large and correlative effects on RNR inhibition and free radical quenching potency have been 
reported, therefore Polyhydroxyphenyl compounds are thought to work by free radical 
scavenging
.  
6
 
.  
The library procured from Find a drug had a diketopiperazine nucleus with several compounds in 
the library containing a dihydoxybenzyl- group connected to a chiral carbon. Reterosynthesis of 
the compounds suggested a two step synthetic process involving the Ugi reaction, a four-
component one pot reaction usually carried-out in methanol, followed by cyclization with 10% 
trifluoroacetic acid in dichloroethane (Figure 3.3). 
 20 
  
 
 
 
 
Figure 3.1 
 
Figure 3.1 Type II Fatty Acid System. Acetyl-COA is carboxylated by acetyl-CoA carboxylae 
(ACCABCD) to malonyl CoA, which is transferred to Acyl Carrier Protein by malonyl-CoA: 
ACP tramsacylase (FabD). This is then condensed by β-ketoacyl-ACP synthase (FabH) followed 
by fatty acid elongation carried out by iterated cycles of condensation catalyzed by β -ketoacyl-
ACP synthases (FabH, FabB/FabF), reduction by b-ketoacyl-ACP reductase (FabG), dehydration 
by b-hydroxyacyl-ACP dehydratases (FabA/FabZ) and reduction by enoyl-ACP reductase 
(FabI)7
 
. Figure adapted from Pidugu, S, L; Kapoor, M; Surolia, N;  Surolia, A; and Suguna, K; 
Journal of Molecular Biology; 343, (1), 147-155 (2004) 
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Figure 3.2 – Target diketopiperazine 
 
 
 
 
Scheme 3.1 – Reterosynthesis of the target diketopiperazine 
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Scheme 3.2 Proposed dehydration mechanism for DOPAL synthesis 
  
 
One of the compounds we attempted to synthesize was the diketopiperazine 1(Figure 3.2). The 
diketopiperazine (1) could be possibly synthesized in two steps i) a 4-component Ugi reaction 
which would yield a diamide (2). ii) This diamide in 10% TFA in 1, 2-dichloroethane is 
suggested to undergo cyclization8
The Ugi reaction involves the reaction of 3,4-dihydrophenylacetaldehyde [DOPAL] (6), 5-
Methyl-2-furylmethylamine (3), N-(tert-Butoxycarbonyl)-L-methionine, Boc-L-methionine (4) 
and  benzylisocyanide (5) in methanol at room temperature.  
 to afford the target diketopiperazine (1).  
 23 
All starting materials except 3, 4-dihydrophenyl acetaldehyde were commercially available. 
Therefore a synthetic procedure had to be designed.  
3.4 Synthesis of 3, 4-dihydrophenylacetaldehyde [DOPAL] 
Synthesis based on an earlier work reported by Robbins9 in 1966 by a pincol-pinacolone 
rearrangement of adrenaline. However here we propose a much simpler dehydration followed by 
an imine hydrolysis mechanism, which is more plausible than the rearrangement itself 
(Figure3.4). HNMR of the product isolated matches one reference10 and differs with another 
one11
Another method found in the literature
. 
12
Procedure: A solution of adrenaline (1.0g 5.5mmoles) in 85% phosphoric acid was heated (116-
118C) in a round bottom flask (for 1hour) in a heating mantle then removed from heat and 
allowed to cool. The solution was stirred for 90 min in distilled water and then saturated with 
NaCl. It was taken up in diethyl ether, and dried over anhydrous MgSO4. The ether extract was 
then evaporated to obtain DOPAL (80 mg 0.53mmol), 9.5% yield
, suggested a single step rearrangement using perchloric 
acid in glacial acetic acid. This method was however discarded in support of previously 
mentioned, Robbins method, due to the explosive nature of perchloric acid.  
13
3, 4-dihydroxyphenylacetaldehyde:  C8H8O3; brown oil: 1H NMR (
. 
 ppm, CDCl3 500Mz) 3.4 
(bs, 2H), 3.6 (s, 2H), 9.7 (s, 1H), 6.4-6.8 (aromatics, 3H). TLC: 6:1 methylene chloride / 
methanol Rf 0.66                                                   
Acknowledgements: I would like to thank Alicia Holsey, James Giammarco, and Sean Gardner 
for there work with imine synthesis and initial attempts at the Ugi reactions. [For details: See 
http://usefulchem.wikispaces.com/All+Reactions] 
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Figure 3.4 TLC of 3,4-dihydroxypehnylacetaldehyde (6) from two different experiments against epinephrine 
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Chapter 4: Initial attempts at Ugi reaction and imine kinetics 
4.1: Introduction 
The Ugi reaction is a one pot four component condensation reaction of an aldehyde, amine, 
carboxylic acid and an isocyanide. The reaction was discovered by Ivar Ugi in 1959 for the 
synthesis of a local anesthetic Xylocaine. Owing to the efficiency and the ease of automation, 
and the vast number of products that can be synthesized over a short period of time, the Ugi 
reaction finds an important place both in academia and industries in the search for biologically 
active novel compounds.  
 
Our initial attempts of the Ugi reaction involved 5-methylfurfylamine, benzaldehyde or 
phenylacetaldehyde, boc-methionine or boc-glycine and benzylisocyanide. The reactions were 
not successful owing to the acidic nature of the alpha protons on phenylacetaldehyde, which 
possibly undergoes base catalyzed reactions. 
 
In order to get a better understanding of the mechanism of Ugi reaction, it was deemed necessary 
to perform a proton NMR study after the addition of each component during the reaction. The 
reaction was performed in an NMR tube. 
 
Previous work done on the mechanism of the Ugi reaction had indicated that the reaction passes 
through different stages, similar to a step wise reaction1. It was suggested that the first step of the 
reaction was the imine (1 scheme 4.1) formation with a subsequent conversion to the imminium 
ion. The imminium ion (2 scheme 4.1) then is well placed for a nucleophilic attack by the 
isocyanide (3 scheme 4.1), followed by the carboxylate addition. Once all four components are 
28 
 
incorporated in to the system, it undergoes a rearrangement to form a five membered 
‘munchnone’ intermediate (5 scheme 4.1), which falls apart to form the Ugi product (6) 2,3
 
. 
A Mechanistic Insight – The Ugi reaction 
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Scheme: 4.1: A Plausible mechanism for the Ugi reaction. 
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4.2 Imine Kinetics 
Based on the mechanistic insight, we decided to perform an imine and then add the remaining 
components to the reaction mixture. Inorder to study the chemical conversion during the course 
of the reaction we decided to run the reaction in an NMR tube and study it with proton NMR. 
 
One of the first reactions we studied with was the reaction of phenylacetaldehyde with t-butyl 
amine. The aldehyde was chosen because of it was a close analog of DOPAL; the aldehyde of 
interest we wanted to make the diketopiperazine, a potential anti-malarial agent suggested by 
Find-A-Drug docking studies against Plasmodium flaciparum enoyl reductase. 
 
  An excess (30%) of aldehyde was reacted with the amine in CDCl3.  The reaction was 
monitored by HNMR. It was clear with in five minutes that phenylacetaldehyde does not react 
cleanly with t-butyl amine. Although it had been reported in the literature4
Imine kinetics for the reaction of veratraldehyde and 5-methylfurfurylamine was also studied in 
CDCl3 and CD3OD. The reaction rate for the formation of imine in deuterated chloroform was 
measured at 1.00 x 10-2 /M*min and the same reaction in deuterated methanol was measured to 
be 1.06 x 10-1 /M*min. 
 of the imine between 
phenylacetaldehyde and t-butyl amine in CCl4, it was characterized by NMR and had been used 
as a crude product in a subsequent step. Despite the side reactions of phenylacetaldehyde with t-
butyl amine, an imine is formed with a rate constant k = 8.527 /M*min (Figure: 4.1). 
Similar experiments carried out for in either CDCl3 or CD3OD clearly indicated that aromatic 
aldehydes react much slowly compared to aliphatic aldehydes with 5-methylfurfurylamine and   
t-butylamine (Table 4.1). Similar rate constants have been reported in the literature for the imine 
formation5.  
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Table 4.1: Rate constant for the imine formation 
 
 
 
 
Figure: 4.1 Target diketopiperazine 
 
 
aldehyde amine solvent 
imine formation 
rate constant  
1/(M*min) 
UsefulChem  
Experiment  
number/ Researcher 
phenylacetaldehyde t-butyl amine CDCl3 8.527 Exp0446
veratraldehyde 
/Mirza, K 
5-methylfurfurylamine CDCl3 0.01 Exp0457
veratraldehyde 
/ Mirza,K 
5-methylfurfurylamine CD3OD 0.106 Exp0468
piperonal 
/ Mirza, K 
5-methylfurfurylamine CDCl3 0.07 Exp0409
piperonal 
/Holsey, A 
5-methylfurfurylamine CD3OD 0.1552 Exp04310
piperonal 
/Holsey, A 
t-butyl amine CD3OD 0.008 Exp04811
3,4,-
dihydroxybenzaldehyde 
/Gimmarco, J 
5-methylfurfurylamine CD3OD 0.1043 Exp04712/ Gardner, S 
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4.3 Initial Ugi reactions 
During the initial stages of the Ugi reaction, we primarily used only a few selected reactants 
which included veratraldehyde, piperonal, 5-methylfurfurylamine, boc-glycine, boc-methionine, 
2-morpholinoethyl isocyanide and benzyl isocyanide.  The rationale behind using a restricted 
few reactants was the fact that these reactants either the precursors the diketopiperazine 7 (figure 
4.1) we intended make or they were close analogs of reactants which formed 7. 
Due to the vile odor of benzyl isocyanide, 2-morphilonoethyl isocyanide was chosen, which does 
not have an odor. However during the course of experimentation it was realized that 2-
mopholinoethyl isocyanide was not compatible with boc-glycine. Therefore a proton NMR study 
was carried out, where equimolar amounts of boc-glycine and the isocyanide was placed in an 
NMR tube in CDCl3 and the changes were monitored. It became clear with-in the first two 
minutes itself that boc-glycine and 2-morpholinoethyl isocyanide had reacted13
Similar compatibility study was carried out on boc-glycine and benzyl isocyanide and boc-
glycine and tert-butylisocyanide. The chemicals remained stable and unreactive towards each 
other after several hours of monitoring by NMR
. Therefore, 2-
morpholinoethyl isocyanide was discarded as an option since then for the Ugi reaction.  
14,15
A Ugi reaction involving veratraldehyde, 5-methylfurfurylamine, boc-glycine and t-
butylisocyanide was performed (Scheme 4.2) in methanol-d4. The imine was preformed and 
confirmed by HNMR. Once the acid and the isocyanide were added to the preformed imine, 
some of it reverted back to aldehyde and amine. In this case, the imine reversal was not as 
pronounced as had been found in other experiments
. Therefore benzyl isocyanide was one of the 
primary isocyanides used initially. 
16
 
. However a Ugi product was isolated after 
two hours of sitting. 
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Scheme 4.2 A general scheme of the Ugi reaction 
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Table 4.2 Reagents, products and yields 
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4.4 Experimental  
 
Compound 8: tert-Butyl (2-{[2-(tert-butylamino)-2-oxo-1-phenylethyl](2-furylmethyl)amino}-
2-oxoethyl)carbamate 
A solution of benzaldehyde (212 uL, 2 mmol) and fufurylamine (120uL uL, 2.2 mmol, 10% 
excess) was made in methanol in a 4mL volumetric flask. After about two and half hours 
solution of boc-glycine 350 mg, 2 mmol), and tert-butyl isocyanide (226 uL, 2 mmol) made up in 
4 ml volumetric flask in methanol was added the preformed imine solution. A crystalline Ugi 
product was obtained which was filtered and washed with methanol.  
C24H33N3O5;  White solid; m.p. 202-204C; 1H NMR (500MHz,  ppm, CDCl3) 1.33 (s, 9H), 1.45 
(s, 9H), 4.21 (m, 2H), 4.49 (d, J=18Hz, 1H), 4.50 (d, J=18Hz, 1H), 5.47 (s, 1H), 5.60 (s, 1H), 
5.62 (s, 1H), 5.89 (s, 1H), 6.10 (s, 1H), 7.19 (s, 1H), phenyl 7.21-7.37 (m, 5H); 13C NMR ; 
(500MHz, ppm, CDCl3) 28.3, 28.6, 42.3, 42.8, 51.7, 62.9, 79.5, 107.7, 110.4, 128.5, 128.7, 
129.6, 134.7, 141.9, 149.8, 155.7, 168.4, 170.2; IR (Ʋmax cm-1 ATR): 1645, 1673, 1699, 3331; 
FAB-HRMS -calculated for C24H34N3O5 m/z 444.2498 [M+H], obtained 444.2517 [M+H]. Yield 
37%, 331mg 
 
Compound 9: tert-Butyl (2-{[2-(benzylamino)-1-(3,4-dimethoxyphenyl)-2-oxoethyl][(5-methyl-
2-furyl)methyl]amino}-2-oxoethyl)carbamate 
Dissolved 3,4-dimethoxybenzaldehyde (veratraldehyde) (332mg, 2mmol) and 5-
methylfurfurylamine( (244uL, 2.2mmol, 10% excess ) in 4mL methanol-d4 in a 4mL volumetric 
flask immediately transferred the contents to a 25mL Erlenmeyer flask. The reaction is allowed 
to sit for about 6 hours without stirring to form the imine. A solution of boc-glycine (350mg, 2 
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mmol), and benzyl isocyanide (240uL, 2mmol) is made up in 4ml volumetric flask in methanol-
d4. This solution of boc-glycine and benzyl isocyanide is added to the preformed imine. The 
reaction mix is allowed to sit undisturbed overnight, when the Ugi product is obtained. The 
product is recrystallized from a small amount of methanol.   
C30H37N3O7C; White solid; Mp- 176-177C; 1H NMR (  ppm, 500MHz, CDCl3) 1.44 (s, 9H), 2.1 
(s, 3H), 3.72 (s, 3H), 3.86 (s, 3H), 4.196 (s, 2H), 4.32-4.64 (m, 4H), 5.64-5.46, (s, 2H), 6.70-6.82 
(m, 2H), 6.83-6.93 0(m, 1H), 7.15-7.40 (m, 8); 13C NMR (  ppm, CDCl3) 13.3, 28.2, 42.5, 42.8, 
43.5, 55.67, 55.8, 63.1, 79.5, 106.2, 108.8, 110.7, 112.7, 122.3, 126.4, 127.4, 127.6, 128.5, 137.9, 
147.7, 148.9, 149.2, 151.7, 155.7, 169.28, 170.150; IR (Ʋmax cm-1 ATR) 3250.01, 1692.10, 
1665.94, 1644.09, 1516.65, 1147.11; HRMS (CI-methane): m/z calcd for C30H38N3O7 [M+H] 
552.270976, found 552.270854 [M+H]. Yield 44%, 483.7mg. 
 
Compound 10:  tert-Butyl (2-{[2-(tert-butylamino)-1-(3,4-dimethoxyphenyl)-2-oxoethyl](2-
furylmethyl)amino}-2-oxoethyl)carbamate 
A solution of veratradlehyde (332 mg, 2 mmol) and furfurylamine (234.8 uL, 2.2 mmol, 10% 
excess) was prepared in methanol-d4 in a 2mL volumetric flask to form an imine. After two 
hours a solution of boc-glycine (350 mg, 2 mmol), and tert-butylisocyanide (226 uL, 2 mmol) 
made-up in a volumetric flask in methanol-d4 was added to the preformed imine. The Ugi 
product (10, table 4.2) was filtered and washed with ice cold methanol (5mL).  
C26H37N3O7; White solid; 1H NMR (  ppm, CDCl3) 1.34 (s, 9H), 1.45 (s, 9H), 3.76 (s, 3H), 3.87 
(s, 3H), 4.22 (s, 2H), 4.48 (s, 2H), 5.49-6.12 (m, 5H) 6.71-6.88 (m, 3H), 7.20 (s, 1H) 13C NMR (  
ppm, CDCl3) 28.3, 28.5, 42.0, 42.8, 51.6, 55.7, 55.8, 62.5, 79.5, 107.4, 110.4, 110.7, 112.6, 
122.0, 126.7, 141.7, 148.9, 149.9, 150.0, 155.6, 168.7, 170.2; HRMS (FAB,m-nitrobenzyl 
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alcohol): m/z calcd for C26H38N3O7,  504.2704 [M+H], found 504.2725 [M+H]. Yield 12%, 
120mg. 
 
Compound 11: tert-Butyl (2-{[2-(benzylamino)-2-oxo-1-phenylethyl](2-furylmethyl)amino}-2-
oxoethyl)carbamate 
A solution of benzaldehyde (212 uL, 2.09 mmol) and furfurylamine (FFA) (235uL, 2.66 mmol) 
was prepared in methanol-d4 in a 4mL volumetric flask to form an imine overnight. The next 
day a solution of boc-glycine (350 mg, 1.99 mmol), and benzylisocyanide (240uL, 1.97 mmol) 
made up in a 4ml volumetric flask in methanol was added to the preformed imine. The product 
was filtered and washed with ice cold methanol (5mL).  
 C27H31N3O5: Colorless Crystals; m.p. 146-148C; 1HNMR ( ppm, CDCl3) 1.43 (s, 9H), 4.18 (m, 
2H), 4.43 (m, 2H), 4.48 (s, 2H), 5.46 (s, 1H), 5.68 (s, 1H), 5.94 (s, 1H), 6.09 (m, 1H), 6.30 (s, 
1H), 7.10-7.50 (m 11H) 13C NMR (  ppm, CDCl3) 28.3, 42.5, 42.8, 43.6, 63.0, 79.5, 107.9, 
110.3, 110.8, 127.4, 127.6, 128.6, 128.7, 129.6, 134.2, 137.7, 142.0, 149.5, 155.7, 169.0, 170.3; 
FAB HRMS: m/z calcd for C27H32N3O5 [M+H] 478.234197 found 478.2366 [M+H]. Yield 20.4 
%, 192mg. 
 
Compound 12: (2E)-N-[2-(tert-Butylamino)-2-oxo-1-(9-phenanthryl)ethyl]-N-heptylbut-2-
enamide 
To a one dram vial, charged with methanol (0.5mL) heptylamine (148.3uL, 1mmol), 
phenanthrene-9-carboxaldehyde (206mg, 1mmol), crotonic acid (87mg, 1mmol) and tert-butyl 
isonitrile (113.1uL, 1mmol) was added in that order. After the additions the vials containing the 
reaction mixture was sonicated to ensure a clear solution was obtained. The solution was left 
undisturbed for three hours when the product precipitated out. The obtained solid was washed 
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with methanol (3 x 500uL), centrifuged each time to obtain a white residue. The wet product was 
set under a high vac to remove the solvent. 
 C31H40N2O2: White powder; m.p. 179-181C; 1H NMR (  ppm, CDCl3) 0.30 (m, 1H), 0.54-0.95 
(m, 10H), 1.05-1.2 (m, 1H ), 1.39 (s, 9H), 1.89 (d, 3H J 6.8Hz), 2.86 (bs, 1H), 3.28-3.60 (m 2H ), 
5.79 (s,1H), 6.24 (d,1H J 15Hz), 6.87 (s 1H), 7.0-7.15 (m 1H), 7.56-7.76 (m 4H), 7.88 (d 1H J 
7.85 Hz), 7.92-8.04 (m 2H), 8.68 (d 1H J 8.25 Hz), 8.73 (d 1H J 8.25Hz); 13C NMR (  ppm, 
CDCl3) 13.8, 18.2, 22.1, 26.2, 27.9, 28.6, 29.9, 31.0, 45.5, 51.7, 57.8, 122.0, 122.4, 123.1, 124.1, 
126.8, 126.9, 127.43, 127.48, 128.9, 129.15, 129.16, 130.3, 130.47, 130.9, 131.0, 142.7, 166.9, 
169.9; IR (KBr, Ʋmax cm-1) 3315, 3080, 2926, 2855, 1663, 1614, 1452, 1419, 748, 728; HRMS 
m/z calcd for C31 H40 N2 O2 : 495.298748 [M+Na]; found 495.2997 [M+Na]. Yield 70.4%, 
333mg. 
 
Compound 13: (E)-N-benzyl-N-[2-(tert-butylamino)-2-oxo-1-(9-phenanthryl)ethyl]but-2-
enamide 
To a one dram vial, charged with methanol (0.5mL) benzylamine (1mmol, 109.2 uL), 
phenanthrene-9-carboxaldehyde (1mmol, 206mg), crotonic acid (1mmol, 87mg) and tert-butyl 
isonitrile (1mmol, 113.1uL) was added in that order. After the additions the vials containing the 
reaction mixture was sonicated to ensure a clear solution was obtained. The solution was left 
undisturbed for three hours when the product precipitated out. The obtained solid was washed 
with methanol (3 x 500uL), centrifuged each time to obtain a white residue. The wet product was 
set under a high vac to remove the solvent.   
C31H32N2O2 :White powder; H-NMR (  ppm ppm, CDCl3) 1.39 (s, 9H), 1.77 (d, 3H J=6.3Hz), 
4.79 (d, 1H, J=17.9 Hz), 4.88 (d, 1H, J=17.9 Hz), 5.67 (s, 1H), 6.18 (d, 1H, J=15.0 Hz), 6.33-
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6.81 (m, 4H), 6.88-7.23 (m 2H ), 7.36-7.74 (m, 4H), 7.80 (d,1H J=7.3 Hz), 7.90 (s 1H), 8.09 (d 
1H J 12.2 Hz), 8.51 (t 2H J=12.8Hz); 13C NMR (  ppm, CDCl3) 18.1, 28.6, 49.0, 50.6, 51.7, 
57.6, 94.6, 122.2, 122.4, 122.9, 124.2, 125.8, 126.6, 126.68, 127.1, 127.2, 128.7, 129.3, 130.1, 
130.2, 130.4, 130.7, 30.9, 137.3, 143.4, 168.0, 169.9 ; IR (KBr Ʋmax cm-1) 3323, 3058, 2969, 
1677, 1655, 1594, 1526, 1421, 722, 695; HRMS m/z calcd for C31H32N2O2 : 465.2542 [M+H] 
found 465.2448; C31H32N2O2Na 487.23614 [M+Na] found 487.23761[M+Na]. Yield 64.3%, 
299mg. 
 
Acknowledgements: Alicia Holsey, James Giammarco and Sean Gardner for their work on imine 
kinetics and initial Ugi reaction attempts. 
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Chapter 5 – The Fufuryl cleavage 
5.1 – Introduction 
In the quest for a 2,5-diketopiperazine (6 Scheme 5.1) synthesis, we came across a method which 
called for the treatment of a Ugi product (5 Scheme 5.1) with 10% trifluoroacetic acid (TFA) in 
1,2-dichloroethane (DCE) to effect a transamidation-cylization1
 
 (scheme 5.1). However to our 
frustration, the method did not yield the desired cyclized product (6 Scheme 5.1). Therefore we 
decided to monitor the reaction of a Ugi product with TFA in DCE.  All Ugi products we had 
synthesized previously contained a 5-methylfuran system on nitrogen of a secondary amide (R2, 
Table 5.1). This system was lost upon treatment with TFA (Scheme 5.1). In this chapter, the 5-
methylfuran other wise called as the ‘furfuryl cleavage’ is discussed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5.1 Ugi reaction and Furfuryl Cleavage  
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5.2 – Acid catalyzed ring opening reactions of furfuryl alcohols 
The Ugi products we synthesized contained a boc-protected amine. Under acidic conditions, it was 
expected undergo a boc-deprotection followed by a transamidation cyclization. When the Ugi 
product was subjected to 10% trifluoroacetic acid in 1,2-dichloroethane a diketopiperazine was not 
formed. Although an initial boc-deprotection was observed, an unusual break-down of the Ugi 
products was also seen where the furfuryl group on the nitrogen of an amide in the molecule was 
cleaved, leaving the remaining molecule in tact. The pattern was seen in several Ugi products 
containing the N-furfuryl group. 
Furan containing systems, especially furfuryl alcohols have been reported to undergo ring opening 
reactions.2 However, a furfuryl amide cleavage has not been observed in the literature. Hoffmann 
and Shechter in 1974 reported that furylcarbinols with protic acids (fluoroboric acid) gave 
carbenium (furylium) salts3. Similar cations have also been reported by Bose, et.al4. However in 
many cases, ring opening of furan is involved, as in the indole synthesis from 2-
tosylaminobenzofurans (16), which leads to the formation of a carbonyl compound (20)5,6 (Scheme 
5.2).  
  
Scheme 5.2– Indole synthesis, Reissert modification  
(Scheme adapted from Butin, A.,V; Stroganova, T.; Lodina, I., V.; Krapivin, G., D.;  Tet. Lett; 42; 
10; 2031-2033; 7) 
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However, other routes have been suggested to the ring opening of furans under acidic conditions 
which allows a molecular rearrangement. In one such rearrangement catalyzed by ZnCl2, 
cylcopentenone derivatives were synthesized (25) 8
 
 (Scheme 5.3). 
  
 
Scheme 5.3 – Furan ring opening leading to a cyclopentanone derivative from furfuryl alcohols 
Scheme adapted from Piancatelli, G.; Scettri, A.; David, G.; D’Auria, M.; Tetrahedron; 34; 18;  
2775-; (1978) 
 
5.3 – Furfuryl cleavage: A case for 1, 6 - Elimination. 
Winberg, Fawcett, et.al. in 1959 reported a 1,6-Hoffman type elimination reaction of 5-methyl-2-
furyltrimethyl ammonium hydroxide to 2,5-dimethylene-2,5-dihydrofuran (27, Scheme 5.4)9. It is 
important to emphasize here that the Hoffman elimination is initiated by a base and mostly requires 
heat, however here by employing trifluoroacetic acid a methyl furfuryl group on the amide nitrogen 
is lost. 
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A 1,6-Hoffman type elimination reaction of 5-methyl-2-furfuryl trimethylammonium hydroxide 
was reported by Winberg and coworkers in 1959. According to the authors, ‘appropriately 
substituted quaternary ammonium hydroxides undergo loss of trimethyl amine across a furan or 
thiophene to unusual cyclic conjugated trienes, there dimmers and polymers. As an example the 
authors use 5-methyl-2-furfuryltrimethyl ammonium hydroxide, which upon pyrolysis yielded 2, 5-
dimethylene-2, 5-dihyrofuran (27) [scheme 5.4 and 5.5], which was isolable at -78C. The triene 
(21) when warmed to room temperature under went polymerization (28).  However when the same 
triene was warmed to room temperature in the presence of polymerization inhibitors dimerized in 
high yields to a heterocyclophane, [2,2] (2,5) furanophane (29), which is a furan analog of 
[2,2]paracyclophane.  
O
N
+
(CH3)3
R
OCH2 CH2
R= H, CH3, C6H5
O
x
O
O
furan analog of 2,2-[paracyclophane]
polymerization inhibitors26
27
28
29
  
 
Scheme 5.4 – 1, 6-Hoffman elimination of quaternary amines 
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Scheme 5.5 – Mechanism of a 1, 6-Hoffman elimination of 5-methyl-2-furyltrimethyl ammonium 
hydroxide. 
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A similar 1, 6-Hofman type elimination, induced by fluoride ion had been used to prepare [2.2] 
paracyclophane, [2.2]-(2.5) thiophenophane and [2.2] (2.5) furanophane as well10. Similarly, few 
other cyclophanes, including, [2.2] (2.5) pyrrolophanes have also been reportedly synthesized11
5.4 – Results and Discussion 
. 
We observed that 5-methyl-2-furfuryl group on nitrogen of a tertiary amide, in the Ugi products; 
undergo a 1-6-elimination to yield a secondary amide when treated with trifluoroacetic acid in 
CDCl3 or CD3OD.  There is essentially a loss of 2, 5-dimethyl furan from the system.   
Our investigation in to the process involved a few Ugi products and derivatives of 5-methyl 
furfuryl amine (11) and furfuryl amine (12). The first compound investigated was compound 33 
(Scheme 5.6). The Ugi product 33 was synthesized from veratraldehyde (9), 5-methylfurfuryl 
amine (11), boc-glycine (13) and benzyl isocyanide (14) in methanol. It is obtained as a white 
powder.  
When the Ugi product 33 was exposed to TFA (10%) in CDCl3, there was initial boc-deprotection 
of the amine. The deprotection process took almost five and half hours to reach completion. It 
followed first order kinetics with a rate constant of 1.22x10-2 s-1.  The side product of the 
carbamate hydrolysis was tert-butyl trifluoroacetate12
When the reaction was left to run further and monitored by HNMR, compound 34 under went a 
slow loss of methyl group at 2.1 ppm, a methylene signal between 4.3-4.5 ppm and the furan 
protons at  5.7 ppm and 5.8ppm .(Figures 5.1 and Figure 5.2)
.  
13.  The rate constant for this loss, the 
1, 6-elimination of methyl furfuryl group follows first order kinetics with k = 0.9x10-3 min-1 as the 
rate constant 14
 
 (Figure 5.1). 
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 Scheme 5.6 – Observed furfuryl cleavage 
 
 
 
 
 
  
 
Figure 5.1 – Kinetics of 1, 6-methyl furfuryl elimination of the Ugi product 33. 
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Similar results were obtained when the Ugi product 36 was treated with 50% TFA solution in 
CDCl3. There was an initial deprotection of the Boc group followed by a 1, 6-methyl furfuryl 
elimination. The rate of the elimination reaction was estimated to be k = 1.2x10-3 min-1 (Fig 5.4). 
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Scheme 5.7 – Product after 5-methylfurfuryl cleavage of the Ugi product 36 
 
 
 
 
 
Figure 5.4 – Kinetics of 1, 6-methyl furfuryl elimination of the Ugi product 36. 
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Proton magnetic spectrum of the Ugi product 14 (Fig 5.5) and one on the third day of the reaction 
in 50% TFA – CDCl3 (Fig. 5.6), shows two new doublets at 8.42 ppm and 5.47 ppm. The two 
doublets were coupled (J= 6.8Hz).  There was a complete disappearance of the methyl group at 
2.16 ppm (Fig. 5.5 and 5.6). This is again consistent with a 1,6- methyl furfuryl loss.  
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Scheme 5.8 – Product after 5-methylfurfuryl cleavage of the Ugi product 39 
 
Similar experiments were conducted with a different Ugi product 39. In this case again, the Ugi 
product was treated with 50% TFA – CDCl3 solution. As expected a 1,6-methylfurfuryl loss was 
observed.  The kinetics of the cleavage was yet again found to be first order with a rate constant k 
= 0.9x10-3 min-1.(Fig 5.6)  The disappearance of a methyl group at 2.12 ppm was relative to the rate 
of appearance of two coupled doublets at 8.48 ppm and 5.57 ppm (J= 6.8Hz) Fig( 5.7) 
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Figure 5.7 –Kinetics of 1, 6-methyl furfuryl elimination of the Ugi product 39 
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In order to explain the unusual cleavage of N-CH2 bond, the missing methyl puzzle15
It is assumed that after an initial protonation on the amide oxygen followed by the development of 
a quaternary nitrogen (42), the methyl furfuryl group is lost as 2, 5-dimethylene-2,5-dihydrofuran 
(27). This is consistent with the HNMR data which shows the NH peak around 8.4 ppm which is 
coupled to the chiral proton at 5.4 ppm. The resultant secondary amide (43) after cleavage was 
confirmed by NMR and mass analyses. A proposed general mechanism for 1, 6-methyl furfuryl 
cleavage has been depicted in scheme 5.9. The triene (27) is known to undergo polymerization (48) 
at room temperature in the absence of polymerization inhibitor. The polymer does not show-up on 
HNMR cleanly and appears only as baseline contamination. Since the parent triene of the polymer 
is a result of furfuryl cleavage, the methyl associated with the group on the Ugi product also 
disappears. 
 resulting in 
the loss of the methyl furfuryl from the tertiary amides in trifluoro acetic acid, a mechanism which 
places a proton on O has been proposed.  This also corresponds to the disappearance of the methyl 
group. 
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 Scheme 5.9 – A possible pathway for the 1,6-methyl furfuryl cleavage 
 
 
 
 
55 
Although the above proposed mechanism explains the 1, 6-methyl furfuryl cleavage from a tertiary 
amide and thus the disappearance of the methyl group at 2.1ppm, it also suggests that such a 
reaction is unlikely to occur in the absence of the methyl group on furan. The hypothesis was 
supported by the slow elimination in the non-methylated analog of the Ugi product 39 (Scheme 
5.10) 
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Scheme 5.10 – Comparison of furfuryl cleavage at 50% acid concentration 
When the methyl furfuryl group is replaced with furfuryl group in the Ugi product (44) and 
exposed to a solution of TFA/ CDCl3, the boc- deprotected ammonium trifluoacetate salt (45) 
under went very slow furfuryl cleavage and was several orders magnitudes slower than the methyl 
furfuryl analogs cleavage under the same conditions. 
The kinetics profile for furfuryl cleavage of the non-methylated Ugi product varied significantly 
(Fig 5.10) from the kinetics profile of the furfuryl cleavage of its methylated analog. The furfuryl 
cleavage of the methylated analog follows first order kinetics. A similar kinetics profile was 
expected for the non-methylated analog. However an attempt to plot the kinetics data for the 
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furfuryl cleavage of the non-methylated analog did not result in a clear first order profile (Fig 
5.10). Since the experiment was performed over several weeks, the concentration of the acid and 
the solvent may have depleted and is possibly reflected the kinetics profile of the reaction. 
The sluggish nature of the furfuryl cleavage of the non-methylated analog (44) of the Ugi product 
(39) may be due to the absence of the methyl group on furan which under goes a proton elimination 
in the 1,6-methyl furfuryl elimination forming furanophane (27). We have proposed a pathway 
which likely operates during the furfuryl cleavage (Scheme. 5.11) of the non-methylated furfuryl 
analogs.  
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Scheme 5.11 – A possible mechanism for furfuryl cleavage for the non-methylated analog 
 
Figure 5.10 – An attempted fit for first order kinetics plot for furfuryl cleavage of 44 
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It is evident based on the proposed mechanism that the cleavage invokes the lone pair of electrons 
in to the ring (46), thereby de-aromatizing the system. This could be one of the major reasons for 
the sluggish rate of cleavage. The side product, 2-methylene furanonium ion in acid conditions 
likely under goes polymerization. The product of this reaction is a diamide with out the furfuryl 
group (47). 
 
Conclusion 
Ugi products made from 5-methylfurfurylamine and furfurylamine under go a methyl furfuryl and 
furfuryl cleavage when treated with trifluoroacetic acid in either CDCl3 or CD3OD (10% and 50% 
studied). The non-methylated analog cleavage was several magnitudes slower than the methylated 
analog. The 5-methyl-2-furylmethyl containing Ugi products under go a first order 1,6-elimination 
of the “5-methyl-2-furylmethyl” group.  Although 2-furfuryl methyl groups containing Ugi 
products also underwent “furfuryl cleavage ", a kinetic profile for the cleavage remains to be 
ascertained.  A mechanism based on 1,6-Hoffman elimination has been proposed to explain the 
furfuryl cleavage. 
 
Experimental 
Compound 11: 2-[(2-aminoacetyl)amino]-N-benzyl-2-(3,4-dimethoxyphenyl)acetamide 
General procedure: The Ugi product 11 (51.7 mg, 0.092 mmol) was dissolved in 500uL CDCl3 in 
an NMR tube. Then 500 uL of trifluoroacetic acid was added to the above solution in the tube 
(50% solution in CDCl3). The reaction was monitored by NMR. After the completion of the 
reaction the solution was poured into a centrifuge tube and neutralized using 10% NaOH solution. 
The organic component was extracted from the solution using dichloromethane and dried with 
anhydrous MgSO4. The product was subjected to NMR analysis. Yield - 18% (6mg) 
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C19H23N3O4; brown oil, 1H NMR (  ppm, CDCl3 300Mz) 1.25 (bs, 1H), 1.58 (bs, 2H) 3.83 (s, 3H), 
3.87 (s, 3H), 4.0-4.2 (m, 2H), 4.44 (d, 1H, J=6.1Hz), 5.34 (d, 1H, J= 6.1Hz), 5.87 (m, 1H), 6.8 (m, 
1H), 6.86 (s, 1H), 6.93-9.96 (m, 1H), 7.1-7.2 (m, 3H), 7.26-7.30 (m, 3H) 
Similar procedure was used while performing the kinetics except that the product was not washed 
with the based or isolated. 
Acknowledgements: Alicia Holsey for her initial work on kinetics of furfuryl cleavage of the Ugi 
product containing piperonal, boc-glycine, t-butylisocyanide and 5-methylfurfurylamine. 
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Chapter 6: Automated optimization of a Ugi reaction 
6.1 – Introduction 
 
Scheme 6.1 Optimized Ugi reaction 
 
The Ugi reaction is a multicomponent reaction in which four reactants are combined in a 
single pot to produce peptide like adducts. It is a highly efficient reaction used for the 
synthesis of complex molecular systems1,2,3.  The Ugi reaction is an ecologically benign 
and atom economic reaction. There are four chemical bonds formed while only one 
molecule of water is eliminated during a sequence of steps leading to the formation of the 
linear Ugi adduct. The reaction is usually carried-out at room temperature while the 
product sometimes precipitates out from the reaction mixture4,5
In this chapter, we discuss optimization studies of a specific Ugi reaction involving 
benzaldehyde (1), furfuryl amine (2), boc-glycine (3) and tert-butyl isocyanide (4), using 
.  When it precipitates 
out, the product is then just filtered and washed with the solvent. The product 
precipitation although not consistent is very desirable when performing a scale-up, 
essentially eliminating an expensive chromatographic purification process. In order to 
obtain high yield and purity of the product optimization studies have been performed on a 
Ugi reaction, where the product was filtered directly and washed with the solvent.  
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48-slot Mettler-Toledo MiniBlock6 quipped with filtration tubes. An automated liquid 
handler, MiniMapper7
6.2 – Experimental 
 manufactured by Mattler-Toledo was employed to dispense 
reagents and solvents. The variables during the optimization process included reactant 
concentration, solvent composition and the excess of certain reagents. 
Automated Liquid Handling: A Mini Mapper®, manufactured by Mettler-Toledo, was for 
automated liquid handling. The Mini Mapper® workstation is a multi-functional platform 
used for delivering accurate and precise liquids in a programmed order in to a 48-position 
MiniBlock®. 
The Mini Mapper was programmed to deliver the solvents and the reagents in a specified 
order in to the filter tubes. The order of addition of chemicals followed: additional 
solvent, furfurylamine (2M in methanol), benzaldehyde (2M in methanol), boc-glycine 
(2M in methanol) and tert-butyl isocyanide (2M in methanol).  At least 100 micro liters 
solvent was added initially to each tube, unless noted as excess, where 120 micro liters 
were dispensed. Once the addition of chemicals was complete, the MiniBlock® was 
placed on an automatic shaker. After sixteen hours, the MiniBlock® was connected to 
vacuum line and the precipitated product was filtered off. The product in each tube was 
washed twice with methanol (1mL) by shaking for 15 min after each addition. The 
product in the tubes was dried in a high vacuum dessicator for half an hour. The filter 
tube containing dry product was then weighed to calculate the yield. Purity of the product 
was assed by H-NMR on one sample from each solvent system and concentration.  
Solvents under consideration were THF, acetonitrile 
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6.3 – Characterization of the Ugi product (5): tert-butyl (2-{[2-(tert-butylamino)-2-
oxo-1-phenylethyl](furan-2-ylmethyl)amino}-2-oxoethyl)carbamate:  
C24H33N3O5: white solid; m.p8.(11) 202-204 C; 1H NMR9 (500MHz, ppm, CDCl3) 1.33 
(s, 9H), 1.45 (s, 9H), 4.21 (m, 2H), 4.49 (d, J=18Hz, 1H), 4.50 (d, J=18Hz, 1H), 5.47 (s, 
1H), 5.60 (s, 1H), 5.62 (s, 1H), 5.89 (s, 1H), 6.10 (s, 1H), 7.19 (s, 1H), phenyl 7.21-7.37 
(m, 5H); 13C NMR10 (500MHz, ppm, CDCl3) 28.3, 28.6, 42.3, 42.8, 51.7, 62.9, 79.5, 
107.7, 110.4, 128.5, 128.7, 129.6, 134.7, 141.9, 149.8, 155.7, 168.4 170.2; IR11(Ʋmax 
cm-1 ATR): 1645,1673,1699, 3331; FAB-HRMS12
 
 (calculated for C24H34N3O5 m/z 
444.2498 [M+H], obtained 444.2517.) 
6.4 – Data Analysis 
The reactions were run in triplicates and the yields from the experiments are reported as 
average yields in table 6.1 
“The precipitate yield data was analyzed using the single-factor or two-factor (with 
replicates) analysis of variance (ANOVA) tools available in Microsoft Excel13. For those 
variables found to be statistically significant in the ANOVA analysis, Fisher's Least 
Significant Difference (LSD) test was used to determine the specific experimental 
settings exhibiting significant differences in yield of the Ugi precipitate14. All 
significance tests were performed at the 95% confidence level.”15
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Table 6.1 – Yield of Ugi product precipitate as a function of solvent composition, reagent 
concentration and reagent excess. All averages and standard deviations are for N=3 
replicate reactions. 
Run Solvent concentration (M) ratios average yields 
1 methanol 0.4 Eqimolar 49.41 
2 methanol 0.4 Amine xs 57.31 
3 methanol 0.4 Ald xs 58.62 
4 methanol 0.4 Acid xs 55.39 
5 methanol 0.4 tBUIC xs 58.66 
6 methanol 0.4 Imine xs 66.17 
7 methanol 0.2 Eqimolar 50.84 
8 methanol 0.2 Amine xs 47.20 
9 methanol 0.2 Ald xs 50.47 
10 methanol 0.2 Acid xs 54.15 
11 methanol 0.2 tBUIC xs 57.83 
12 methanol 0.2 Imine xs 57.49 
13 methanol 0.07 Eqimolar 0.53 
14 methanol 0.07 Amine xs 1.09 
15 methanol 0.07 Ald xs 9.06 
16 methanol 0.07 Acid xs 15.03 
17 methanol 0.07 tBUIC xs 9.88 
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18 methanol 0.07 Imine xs 3.23 
19 
ethanol/methanol 
(60/40) 
0.2 Eqimolar 47.99 
20 
ethanol/methanol 
(60/40) 
0.2 Amine xs 48.29 
21 
ethanol/methanol 
(60/40) 
0.2 Ald xs 50.39 
22 
ethanol/methanol 
(60/40) 
0.2 Acid xs 54.04 
23 
ethanol/methanol 
(60/40) 
0.2 tBUIC xs 55.12 
24 
ethanol/methanol 
(60/40) 
0.2 Imine xs 57.91 
25 
ethanol/methanol 
(87/13) 
0.07 Eqimolar 2.25 
26 
ethanol/methanol 
(87/13) 
0.07 Amine xs 1.61 
27 
ethanol/methanol 
(87/13) 
0.07 Ald xs 7.18 
28 
ethanol/methanol 
(87/13) 
0.07 Acid xs 1.43 
29 ethanol/methanol 0.07 tBUIC xs 1.80 
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(87/13) 
30 
ethanol/methanol 
(87/13) 
0.07 Imine xs 0.41 
31 
acetonitrile/methanol 
(60/40) 
0.2 Eqimolar 37.09 
32 
acetonitrile/methanol 
(60/40) 
0.2 Amine xs 41.00 
33 
acetonitrile/methanol 
(60/40) 
0.2 Ald xs 42.88 
34 
acetonitrile/methanol 
(60/40) 
0.2 Acid xs 32.09 
35 
acetonitrile/methanol 
(60/40) 
0.2 tBUIC xs 41.00 
36 
acetonitrile/methanol 
(60/40) 
0.2 Imine xs 37.95 
37 
acetonitrile/methanol 
(87/13) 
0.07 Eqimolar 0.94 
38 
acetonitrile/methanol 
(87/13) 
0.07 Amine xs 1.84 
39 
acetonitrile/methanol 
(87/13) 
0.07 Ald xs 0.90 
40 acetonitrile/methanol 0.07 Acid xs 0.98 
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(87/13) 
41 
acetonitrile/methanol 
(87/13) 
0.07 tBUIC xs 1.20 
42 
acetonitrile/methanol 
(87/13) 
0.07 Imine xs 1.01 
43 
THF/methanol 
(87/13) 
0.2 Eqimolar 7.89 
44 
THF/methanol 
(87/13) 
0.2 Amine xs 8.15 
45 
THF/methanol 
(87/13) 
0.2 Ald xs 8.45 
46 
THF/methanol 
(87/13) 
0.2 Acid xs 10.75 
47 
THF/methanol 
(87/13) 
0.2 tBUIC xs 7.29 
48 
THF/methanol 
(87/13) 
0.2 Imine xs 11.76 
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6.5– Results and Discussion 
6.51 – Effect of solvent composition 
 
 
 
 
Figure 6.116
 
: Effect of solvent composition on the Ugi product precipitate yields at 0.2M 
concentration, includes 40% methanol at this concentration 
 
Figure 6.2 outlines the effect of solvent composition on the yields of the Ugi reaction 
precipitate at 0.2M reagent concentration. At the given concentration yields of the 
reaction performed in four solvents varied significantly [Single factor ANOVA].  
However the precipitate yields in methanol and ethanol did not vary statistically at 95% 
confidence level, when analyzed by Fisher’s Least Significant Difference (LSD) test, 
indicated by a bar on ethanol and methanol. Tetrahydrofuran (THF) proved to be the 
worst solvent for the Ugi reaction. A possible reason for THF being an undesired solvent 
for the reaction, may be attributed its higher solubility of the Ugi product relative to other 
solvents used17
acetonitrile 
. 
0.02M 
methanol 0.05M 
ethanol 0.02M 
THF 0.26M 
 
Table 6.218
 
 – Solubility of the Ugi product 6.1 
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6.52 – Effect of reagent concentration 
Table 6.1 indicates a steep drop in the average yields when the reactions were performed 
at 0.2M and 0.07M concentrations in methanol, ethanol and acetonitrile and the results 
were non-linear. However average yields were similar for reactions performed in 
methanol at 0.2M and 0.4M reagent concentrations. 
 
 
Figure 6.219
 
 – An Outline of the effect of solvent composition and reagent concentration 
on the yield of the Ugi reaction at 0.2M concentration, includes 40% methanol at this 
concentration 
Two factor ANOVA results indicate not only solvent and reagent excess effects but also 
statistically significant solvent and reagent excess effect interactions, when the reactions 
were performed at 0.2M concentration.  Figure 6.2 describes in detail the general effects 
observed and also the interactions. It shows that precipitate yields depend on the solvent 
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used. Bars over the reagents indicate the yields are not statistically different at 95% 
confidence level. When imine or isocyanide is used in excess in methanol and ethanol, 
highest yields were obtained. For acetonitrile yields improved when amine, aldehyde or 
isocyanide was used in excess. No significant yield improvement was observed for the 
reactions performed in THF with any variation except an imine excess which showed 
significantly improved yield. These variable patterns of improved yields for the solvents 
used leads to a statistically significant interaction effect. This may be a result of the 
variable reaction kinetics, product solubility in different solvents, or a combination of 
both.  An examination of Table 6.1, shows that best yield was obtained when the reaction 
was conducted in 0.4M methanol with 1.2 equivalents of excess imine (66%), 0.2M 
acetonitrile/methanol with 1.2 equivalents of excess aldehyde (43%) and 0.2M 
ethanol/methanol mixtures with 1.2 equivalents of excess imine (58%). Poor yields were 
recorder for THF/methanol runs. 
 
 
Figure 6.320: Effect of concentration and reagent excess on the yield of Ugi product 
precipitate in methanol 
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6.53 – Effect of reagent concentration and reagent excess 
 A summary of the effects of the concentration and reagent excess on the Ugi reaction 
precipitate yields in methanol is listed in Figure 6.3. Statistically significant concentration 
and reagent excess effects are observed from the two factor ANOVA results.  
It becomes obvious that the yields are significantly higher at reagent concentrations 0.2M 
and 0.4M than that at 0.07M concentration. There also appears to be a statistically 
significant interaction between the two variables. 
In summary interactions between the solvent, the reagent concentration and the reagent 
excess were observed. However these interactions were not as significant as the solvent 
and concentration effects independently. Similar effects have been noted by others during 
Ugi reaction optimization studies21
Contributions: Prof. Jean-Claude Bradley and Tom Osborne (Mettler Toledo)  arranged 
for the equipment (Minimapper and other Mettler Toledo instruments). Prof. Kevin 
Owens performed the statistical analysis on the results. Experimental work was done by 
Khalid Mirza. 
. 
Conclusion 
Optimization studies conducted on the Ugi reaction of benzaldehyde, furfurylamine, boc-
glycine and t-butyl isocyanide gave a highest yield of 66% from 0.4M methanol with 1.2 
eq. of imine. This result was much higher for the reaction under non-optimized 
conditions, which was 49% at 0.4M equimolar reagent concentration. Results with good 
reproducibility were obtained.    
 
Acknowledgements: Tom Osborne (Mettler-Toledo), Prof. Kevin Owens (Drexel 
University) 
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`Chapter 7: Ugi reactions – Library synthesis 
7.1 Introduction 
Novel receptors and enzyme targets are increasingly being identified as therapeutic targets, 
leading to a demand in the lead discovery and synthesis of new therapeutic agents. Techniques 
which provide a structural variety and allow for a rapid synthesis of thousands or millions of new 
compounds needed for drug discovery are therefore being investigated.  
Combinatorial synthesis has provided chemists with an option of performing multiple reactions 
simultaneously in order to generate libraries of novel compounds which are then tested for 
bioactivity before further screening. This comes in as a boon to chemists as the traditional 
methods of sequential and linear synthesis of individual molecules prove simply too tedious and 
time consuming. First reports of combinatorial synthesis appeared in 19841. In this seminal work 
the authors describes a solid support peptide synthesis for probing viral antigens.2. Around this 
time Bruce Merrifield received the Nobel Prize in chemistry for solid phase peptide synthesis3.  
A year later in 1985, a method for synthesizing several peptides quickly was introduced by 
Richard Houghten. The method was christened as the “tea bag” method4. A revolution in the 
conceptual undertaking of organic synthesis had already started. Synthesis and screening of 
several peptides in drug discovery helped the development of high throughput technology5, 6. 
Need for speed, quantity and quality of synthesis has driven combinatorial chemistry towards 
automation. Modern day scientists use equipments which dramatically reduce the time and 
increase the results several folds compared to manual synthesis7
Until 1992, when Bunin and Elmann synthesized combinatorial libraries of organic compounds, 
combinatorial chemistry was exclusively used for peptide synthesis
.  
8. Combinatorial synthesis 
usually produces mixtures of thousands or millions of compounds and hence deconvolution of 
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the results generally become difficult and cumbersome. However the split method using encoded 
beads for combinatorial synthesis provides synthesis of a library with each compound attached 
individually to a single bead9. Apart from the one bead one compound method10, combinatorial 
libraries have been synthesized using Houghtens’s SCL (synthetic combinatorial libraries). 
Geysen’s iterative methods has also been widely used11,12
Several commercially available drugs are small organic molecules that contain heterocyclic ring 
systems
. 
13,14. Therefore in order to achieve diversity in the library, it is important that the 
building blocks with appropriate functionalities which are easily accessible are used. It is also 
important that the reactions are clean and efficient15
Molecular diversity can be incorporated in to a library efficiently by using multicomponent 
reactions (MCR)
, 
16,17. Multicomponent reactions usually involve three or more starting materials 
in a one pot reaction. It is assumed that these reactions follow the domino effect, in that the later 
reactions are a result of the functionalities produced in the former conversions18
Several multi-component reactions such as the Passerini, Biginelli, Pauson-Khand, Ugi, Strecker 
and other similar reactions are known. However multi-component reactions based on isocyanide 
chemistry has over shadowed the arena of multi-component reactions. Of the several known 
isocyanide based multi-component reactions, the Ugi reaction has been used widely in the 
pharmaceutical industry
.  These reactions 
exhibit a high degree of atom efficiency and are capable of producing complex scaffolds with 
wide structural diversity. All these features make multi-component reactions very desirable in 
combinatorial synthesis. 
19
The Ugi reaction is a four component one pot reaction involving an aldehyde, an amine, a 
carboxylic acid and an isocyanide [Scheme-7.1]. It was discovered by Ivar Ugi in 1959
.  
20,21.  
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It is postulated that the reaction proceeds via an intra-molecular rearrangement resulting in 
acylation of a Nitrogen atom22. This rearrangement is known as the Mum’s rearrangement23. 
Methanol is the usual choice of solvent for the Ugi reaction24
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Scheme 7.1 – General scheme of a Ugi reaction 
 
The operational simplicity, the diversity of the scaffolds produced25
7.2 Library Synthesis 
, and its efficiency makes the 
Ugi reaction one of the most versatile multi-component reactions in terms of designing and 
screening new lead molecules as therapeutic agents.  
Several Ugi reactions were carried out in order to synthesize the products for bio-testing against 
malarial enzyme Falcipain-2.  A discussion of those reactions is included in this chapter with 
analysis and results. A list of the reaction attempts performed has been published in the form of a 
book26
Most reactions were performed for the products which were predicted to exhibit some 
bioactivity, either anti-malarial or anti-tumor. Empirical modeling studies were also performed in 
order to predict the possibility of precipitation during the Ugi reaction. Reactions which were 
predicted to likely yield a solid Ugi product were performed preferentially.  
.  
 76 
Docking and modeling studies were performed by collaborators27 and the results28 in the form of 
‘SMILES code’ were provided. The SMILES codes were translated in to structures using either 
ACD ChemSketch or using online tools29
Anti-malarial activity was estimated by docking experiments performed on plasmodium enzyme 
falcipain-2
.  
30 and enoyl-reductase31
7.3 Ugi product precipitation 
. Based on the structures, suitable starting materials were 
selected and the reactions were performed in glass vials. 
Several Ugi reactions have been reported in the literature, performed under different solvent, 
temperature and reagent conditions, very few of them yield solid products. Therefore we were 
particularly interested in the Ugi reaction which selectively precipitated the product out from the 
reaction mixture, since that would make the synthesis cost effective by evading chromatographic 
purification32
 
.  Very few Ugi reactions which formed precipitates had been reported in the 
literature. Just a couple of them were plain U-4CR which used monofunctionl starting materials. 
Most were performed in methanol and at room temperature. The table below lists some of the 
important conditions under which these reactions were conducted. 
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Reaction 
type 
Solvent 
used Temperature duration Notes 
U-4CR methanol 
room 
temperature 
24h-
45h 
0.3M in methanol 
24h - product 
filtered33
U-4CR 
 
methanol 
room 
temperature 48h 
Boc-protected 
aminoacid azide 
used as acid 
component34
U-4CR 
 
aqueous 
methanol 
room 
temperature 24-48h 
tetrazolodiazepines 
synthesized35
U-4C-
3CR 
. 
water 
room 
temperature 1h 
synthetic beta 
amino acids 
used36
U-4C-
3CR 
. 
methanol 
room 
temperature 3days 
semicarbazone 
derivatives used as 
imines37
 
 
Table 7.1 List of Ugi reactions from the literature which formed precipitates and the conditions 
used 
In this section a review of some the Ugi product precipitation reactions from the literature is 
provided. In a major review article about multi-component reactions, by Alexander Doemling38
Most products obtained after the Ugi reaction did not form clean precipitates, they needed further 
chromatographic purification.  
, 
a co-worker and student of Prof. Ivar Ugi, the author states that ‘mostly the products precipitate 
out in high purity’. Literature searches for such reactions fail to confirm the notion. In-fact only a 
handful of journal article were found which reported Ugi product precipitations 
 According to Maracaccini39 precipitations likely occur due to the close crystal packing of the 
Ugi products. Though this does sound reasonable when one looks at the crystal structure of the 
products reported, what eludes the understanding at this time are the conditions and the reagents 
which lead to the kind of crystal packing leading to the product precipitation  for the Ugi 
reactions in general. 
 78 
7.3.1. Solvents and Ugi product precipitations 
Most Ugi reactions are performed in polar protic solvents like methanol40, ethanol, isopropanol41 
and 2, 2, 2-trifluoroethanaol42,43. However some of the reactions are also carried in other 
solvents like polar, aprotic chloroform, dichloromethane44, THF45, dioxane46, benzene and 
toluene47
We have performed about six hundred (587) Ugi reactions in at least ten different solvent 
systems using thirty one aldehydes, fifteen amines, thirty eight carboxylic acid and thirteen 
isocyanides. About 20% of the reactions formed precipitates, however about 13% of them were 
confirmed to be Ugi products.  
.   
Ugi reactions performed – 511 
Ugi reactions that precipitated a product – 104 (20%) 
Precipitate confirmed to be Ugi products – 65 (13%) 
Precipitate not a Ugi product – 8 
 Although we were interested in all Ugi products, we wanted to avoid the tedious 
chromatographic purification of the products hence we focused only on the reaction that 
precipitated Ugi products48. Therefore another modeling run was performed by Prof Andrew 
Lang our collaborator who returned to us with a set of molecules from the empirical modeling 
run which showed high likelihood of being precipitated out from the Ugi reactions in methanol49. 
Once the reactions were preformed it became obvious that the model was not perfect yet, and 
required input of several Ugi reactions which had precipitated out. Table 7.1 lists 81 Ugi reaction 
and the solvents that were performed from which the Ugi products precipitated out.  Since 
methanol, a highly polar protic solvent was usually the choice of solvent for the reaction, not all 
starting materials dissolved completely at the beginning of the reaction. Therefore, it was 
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important to determine the solubility of each component in the solvent of interest before 
performing the reactions.  
Table 7.2 List of Ugi reaction which formed precipitates 
Si no 
Exp # 
(Compd ID) Aldehyde Amine Acid Isocyanide Solvent 
1 
UCEXP232-
45 o-tolualdehyde furfurylamine Boc-Gly-OH 
1,1,3,3-
tetramethyl
butyl 
isocyanide methanol 
2 UCEXP064C veratraldehyde 
5-methyl 
furfurylamine Boc-Gly-OH 
benzyl 
isocyanide methanol 
3 UCEXP108C benzaldehyde furfurylamine Boc-Gly-OH 
benzyl 
isocyanide methanol 
4 UCEXP109C benzaldehyde 
5-(trifluoro 
methyl)-2-
furylmethyl 
amine Boc-Gly-OH 
benzyl 
isocyanide methanol 
5 UCEXP225-5 piperonal furfurylamine Boc-Gly-OH 
benzyl 
isocyanide methanol 
6 UCEXP225-4 piperonal furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide methanol 
7 
UCEXP232-
04 benzaldehyde furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide methanol 
8 
UCEXP232-
09 
4-methyl 
benzaldehyde furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide methanol 
9 
UCEXP232-
14 
4-(trifluoromethyl) 
benzaldehyde furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide methanol 
10 
UCEXP232-
24 
Diphenyl 
acetaldehyde furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide methanol 
11 
UCEXP232-
44 o-tolualdehyde furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide methanol 
12 
UCEXP232-
49 p-anisaldehyde furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide methanol 
13 UCExp235-2 
4-(trifluoromethyl) 
benzaldehyde furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide methanol 
14 
UCExp238-
12 
phenanthrene-9-
carboxaldehyde t-butylamine crotonic acid 
cyclohexyl 
isocyanide THF 
15 
UCExp238-
25 
phenanthrene-9-
carboxaldehyde 
2-chloro 
aniline Boc-Gly-OH 
cyclohexyl 
isocyanide 
 
 
THF 
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Si no 
Exp # 
(Compd ID) Aldehyde Amine Acid Isocyanide Solvent 
16 
UCExp238-
27 
phenanthrene-9-
carboxaldehyde aniline Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
17 
UCExp238-
28 
phenanthrene-9-
carboxaldehyde benzylamine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
18 
UCExp238-
29 
phenanthrene-9-
carboxaldehyde butylamine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
19 
UCExp238-
30 
phenanthrene-9-
carboxaldehyde 
cyclohexyl 
amine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
20 
UCExp238-
31 
phenanthrene-9-
carboxaldehyde furfurylamine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
21 
UCExp238-
32 
phenanthrene-9-
carboxaldehyde heptylamine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
22 
UCExp238-
33 
phenanthrene-9-
carboxaldehyde hexylamine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
23 
UCExp238-
34 
phenanthrene-9-
carboxaldehyde methylamine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
24 
UCExp238-
35 
phenanthrene-9-
carboxaldehyde propylamine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
25 
UCExp238-
36 
phenanthrene-9-
carboxaldehyde t-butylamine Boc-Gly-OH 
cyclohexyl 
isocyanide THF 
26 
UCExp240-
09 
phenanthrene-9-
carboxaldehyde 
5-methyl 
furfurylamine 
phenylacetic 
acid 
cyclohexyl 
isocyanide THF 
27 
UCExp241-
08 veratraldehyde methylamine 
3,4-
methylenedi 
oxyphenyl 
acetic acid 
cyclohexyl 
isocyanide methanol 
28 
UCExp241-
09 veratraldehyde methylamine 
3,4-
methylenedio
xyphenylaceti
c acid 
cyclohexyl 
isocyanide methanol 
29 
UCEXP173G
/V2B19 
3,5-dimethoxy 
benzaldehyde benzylamine 
Phenyl 
propynoic 
acid 
n-butyl 
isocyanide methanol 
30 
UCEXP174C/
V2B34 
phenanthrene-9-
carboxaldehyde methylamine 
5-
nitrosalicylic 
acid 
n-butyl 
isocyanide methanol 
31 UCEXP215F 
phenanthrene-9-
carboxaldehyde benzylamine 
4-
chlorophenyl
acetic acid 
n-butyl 
isocyanide 
 
 
 
THF 
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Si no 
Exp # 
(Compd ID) Aldehyde Amine 
 
Acid Isocyanide Solvent 
32 UCEXP217-5 
phenanthrene-9-
carboxaldehyde furfurylamine Boc-Gly-OH 
n-butyl 
isocyanide THF 
33 UCEXP225-2 piperonal furfurylamine Boc-Gly-OH 
n-butyl 
isocyanide Methanol 
34 UCEXP231-4 
4-(trifluoromethyl) 
benzaldehyde 
5-methyl 
furfurylamine 
2-methoxy
acetic acid 
n-butyl 
isocyanide THF 
35 
UCEXP232-
12 
4-(trifluoromethyl) 
benzaldehyde furfurylamine Boc-Gly-OH 
n-butyl 
isocyanide Methanol 
36 
UCExp237-
01 
phenanthrene-9-
carboxaldehyde furfurylamine 
phenylacetic 
acid 
n-butyl 
isocyanide Methanol 
37 
UCExp240-
07 
phenanthrene-9-
carboxaldehyde 
5-methyl 
furfurylamine 
phenylacetic 
acid 
n-butyl 
isocyanide THF 
38 
UCExp240-
01 
phenanthrene-9-
carboxaldehyde furfurylamine 
phenylacetic 
acid 
n-butyl 
isocyanide THF 
39 UCEXP175C 
phenanthrene-9-
carboxaldehyde benzylamine 
4-
chlorophenyl
acetic acid 
n-butyl 
isocyanide methanol 
40 UCEXP225-3 piperonal furfurylamine Boc-Gly-OH 
n-pentyl 
isocyanide methanol 
41 
UCEXP232-
13 
4-(trifluoromethyl) 
benzaldehyde furfurylamine Boc-Gly-OH 
n-pentyl 
isocyanide methanol 
42 
 
UCEXP232-
68 m-anisaldehyde furfurylamine Boc-Gly-OH 
n-pentyl 
isocyanide Methanol 
43 
UCExp240-
06 
phenanthrene-9-
carboxaldehyde furfurylamine 
phenylacetic 
acid 
n-pentyl 
isocyanide THF 
44 
UCExp240-
12 
phenanthrene-9-
carboxaldehyde 
5-methyl 
furfurylamine 
phenylacetic 
acid 
n-pentyl 
isocyanide THF 
45 UCEXP086B benzaldehyde 
5-methyl 
furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide methanol 
46 UCEXP099C benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide methanol 
47 UCEXP104C veratraldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide methanol 
48 
UCEXP171K
V2B11 
4-(dimethyl 
amino) 
benzaldehyde methylamine 
1-
pyrenebutyric 
acid 
t-butyl 
isocyanide methanol 
49 
UCEXP171F
V2B6 
2-
naphthaldehyde methylamine 
1-
prenebutyric 
acid 
t-butyl 
isocyanide methanol 
 82 
Si no 
Exp # 
(Compd ID) Aldehyde Amine Acid Isocyanide Solvent 
50 
UCEXP171D/
V2B4 
2-hydroxy-3-
methoxy 
benzaldehyde benzylamine 
1-
prenebutyric 
acid 
t-butyl 
isocyanide methanol 
51 
UCEXP173B/
V2B14 
4-methyl 
benzaldehyde methylamine 
1-
prenebutyric 
acid 
t-butyl 
isocyanide methanol 
52 
UCEXP201-
06 benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide methanol 
53 UCEXP222-1 benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide DMSO 
54 UCEXP222-2 benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide THF 
55 UCEXP222-4 benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide THF 
56 
UCEXP148A-
V1B153 
phenanthrene-9-
carboxaldehyde heptylamine crotonic acid 
t-butyl 
isocyanide methanol 
57 
UCEXP150D
-V1B155 
phenanthrene-9-
carboxaldehyde benzylamine crotonic acid 
t-butyl 
isocyanide methanol 
58 UCEXP187-2 
4-(trifluoromethyl) 
benzaldehyde benzylamine 
methacrylic 
acid 
t-butyl 
isocyanide methanol 
59 UCEXP214C 
phenanthrene-9-
carboxaldehyde benzylamine crotonic acid 
t-butyl 
isocyanide methanol 
60 UCEXP217-3 benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide THF 
61 UCEXP217-4 benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide DMSO 
62 UCEXP225-1 piperonal furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide methanol 
63 
UCEXP232-
01 benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide methanol 
64 
UCEXP232-
06 
4-methyl 
benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide Methanol 
65 
UCEXP232-
11 
4-(trifluoromethyl) 
benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide Methanol 
66 
UCEXP232-
31 2-furaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide Methanol 
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Si no 
Exp # 
(Compd ID) Aldehyde Amine Acid Isocyanide Solvent 
67 
UCEXP232-
46 p-anisaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide Methanol 
68 
UCEXP232-
66 m-anisaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide Methanol 
69 UCExp235-1 
4-(trifluoromethyl) 
benzaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide Methanol 
70 
UCExp236-
07 
4-(trifluoromethyl) 
benzaldehyde hexylamine 
3,3'-
dichloropivali
c acid 
t-butyl 
isocyanide Methanol 
71 
UCExp238-
24 
phenanthrene-9-
carboxaldehyde t-butylamine crotonic acid 
t-butyl 
isocyanide THF 
72 
UCExp238-
37 
phenanthrene-9-
carboxaldehyde 
2-chloro 
aniline Boc-Gly-OH 
t-butyl 
isocyanide THF 
73 
UCExp238-
38 
phenanthrene-9-
carboxaldehyde 
3-chloro 
aniline Boc-Gly-OH 
t-butyl 
isocyanide THF 
74 
UCExp238-
39 
phenanthrene-9-
carboxaldehyde aniline Boc-Gly-OH 
t-butyl 
isocyanide THF 
75 
UCExp238-
40 
phenanthrene-9-
carboxaldehyde benzylamine Boc-Gly-OH 
t-butyl 
isocyanide THF 
76 
UCExp238-
41 
phenanthrene-9-
carboxaldehyde butylamine Boc-Gly-OH 
t-butyl 
isocyanide THF 
77 
UCExp238-
42 
phenanthrene-9-
carboxaldehyde 
Cyclohexyl 
amine Boc-Gly-OH 
t-butyl 
isocyanide THF 
78 
UCExp238-
43 
phenanthrene-9-
carboxaldehyde furfurylamine Boc-Gly-OH 
t-butyl 
isocyanide THF 
79 
UCExp238-
44 
phenanthrene-9-
carboxaldehyde heptylamine Boc-Gly-OH 
t-butyl 
isocyanide THF 
80 
UCExp240-
02 
phenanthrene-9-
carboxaldehyde furfurylamine 
phenylacetic 
acid 
t-butyl 
isocyanide THF 
81 
UCExp240-
08 
phenanthrene-9-
carboxaldehyde 
5-methyl 
furfurylamine 
phenylacetic 
acid 
t-butyl 
isocyanide THF 
 
Note: For a complete list of reaction attempts, refer the Reaction Attempts web services.  
http://onsbooks.wikispaces.com/Reaction+Attempts  
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7.4 –Ugi reaction precipitation trends 
 Before discussing the trends observed in Table 7.2 regarding the propensity of product 
precipitation from the Ugi reaction with respect to the starting materials used and the reaction 
solvent, it is important to emphasize that all the components had formed a clear solution during 
each of the reaction before a product precipitated out. This is obviously very important because, 
had one of the components not completely dissolved in the solvent it would not only render the 
product impure but also could possibly change the kinetics of the reaction. 
A total of 727 Ugi reactions were performed (until November 2010), of which 197 reactions 
resulted in product precipitations. However only 118 were isolated and confirmed to be Ugi 
products, eleven of those precipitates were confirmed not to be Ugi products. 
 
7.4.1 – Carboxylic acids  
One of the trends seen from the Reaction Attempts50
.  
 database which incorporates almost all the 
Ugi reactions performed in the Bradley lab is that, the likelihood of precipitation of the product 
was high when boc-glycine was used as the acid component of the Ugi reaction in methanol. A 
total of 217 reactions were performed using boc-glycine. A total of 79 reactions formed Ugi 
product precipitates (36.4%). When boc-glycine was used in conjunction with cyclohexyl 
isocyanide (35 Ugi reactions), only 16 reactions formed Ugi products precipitates (17%). 
7.4.2 – Boc-glycine and aldehyde combination 
Several aldehydes along side boc-glycine were used these Ugi reactions, benzaldehyde was 
primarily used in conjunction with furfuryl amine and t-butyl isocyanide. This combination 
resulted in the Ugi product precipitation in different solvents and under varied concentrations. 
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Apart from benzaldehyde, other aldehydes including phenanthrene-9-carboxaldehyde, 4-
(trifluoromethy) benzaldehyde, piperonal and veratraldehyde resulted in product precipitation. It 
is appropriate to point here that not all the precipitated products were characterized because these 
reactions were primarily conducted to obtain the precipitation data which was to be used to build 
an empirical model to predict product precipitation. No clear correlation was found between the 
use of any acid with any specific amine used. 
7.4.3 – Isocyanide 
Nine different isocyanides were used in the Ugi reaction preformed.  Table 7.3 shows a list of 
isocyanides against the number of times it had been used, the number of times the reaction 
formed a precipitate and the percentage.  
Isocyanide 
Number of 
reaction 
number of 
product 
precipitations 
percent 
precipitation 
1,1,3,3-tetramethylbutyl 
isocyanide 15 0 0 
1-pentyl isocyanide 16 0 0 
2-chloro-6-methyl phenyl 
isocyanide 1 0 0 
2-morpholinoethyl 
isocyanide 9 0 0 
benzyl isocyanide 16 6 37.5 
cyclohexyl isocyanide 35 6 17 
n-butyl isocyanide 19 2 10.5 
t-butyl isocyanide 108 68 63 
tosylmethyl isocyanide 1 0 0 
 
Table 7.3 – Precipitation trend of boc-glycine when used with different isocyanide 
 
From table 7.3, 63% of the reactions formed precipitates when t-butyl isocyanide was used as the 
isocyanide component. Similarly when benzyl isocyanide was used as the isocyanide component 
during the Ugi reaction, 37.5% of the times the reaction formed precipitate. Cyclohexyl 
isocyanide (17%) and n-butyl isocyanide (10.5%) were less likely to form solid products. 
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The general trends of the isocyanides used in the Ugi reactions were also interesting. From the 
table below (Table 7.3b) t-butylisocaynide returned with 30% Ugi product precipitated reactions. 
Isocyanide 
Number of 
reaction 
number of 
product 
precipitations 
percent 
precipitation 
1,1,3,3-tetramethylbutyl 
isocyanide 32 0 0 
1-pentyl isocyanide 36 1 3 
2-chloro-6-methyl phenyl 
isocyanide 4 0 0 
2-morpholinoethyl 
isocyanide 13 0 0 
benzyl isocyanide 43 6 14 
cyclohexyl isocyanide 77 10 13 
n-butyl isocyanide 138 22 16 
t-butyl isocyanide 266 81 30.4 
tosylmethyl isocyanide 106 0 0 
 
Table 7.4: General trends in terms of isocyanides used in the Ugi reactions (727 reactions) 
Tosylmethyl isocyanide was used in 106 Ugi reactions51, primarily due its odor free nature. 
However, none of the Ugi reaction formed solid product. One of the main problems encountered 
with tosylmethyl isocyanide was its poor solubility in several solvents52 including methanol. Yet 
another problem which had been reported earlier by Van Leusen53
Although 2-morpholino ethyl isocyanide being non smelly isocyanide was initially used for a 
few Ugi reactions, it was discarded soon due its reactivity towards weak carboxylic acids. The 
, et al. was the reactivity of p-
toluenesulfonylmethyl isocyanide toward aldimines in a basic medium, which could be provided 
by any mild base including primary amines in a protic medium.  The paper reports that aldimines 
in basic conditions under go cycloadditions to produce imidazole analogs. Apart from the 
cycloadditions reactions, the paper also suggests that the isocyanide possibly undergoes a 
decomposition and reaction with solvent methanol (if used) under basic conditions. This may 
explain why no Ugi products were obtained with tosylmethyl isocyanide. 
 87 
isocyanide reacted with boc-glycine in methanol-d4 at room temperature54. The isocyanide had 
previously been successfully used in Ugi reactions55
7.5 – Polyaromatics (phenanthrene-9-carboxaldehyde and 1-pyrenebutyric acid) 
.  
Most Ugi reactions were performed in methanol. Usually, solubility of the starting materials was 
not an issue. However, certain polyaromatic building blocks like phenanthrene-9-carboxaldehyde 
and 1-pyrenebutyric acid did not dissolve freely in methanol. This was a major problem in terms 
of maintaining equimolar concentration with respect to other components during the reaction. 
Reactions therefore had to be conducted at lower than optimal concentrations required for 
product precipitation. 
Poor solubility of these reactants not only had a negative effect on the reaction kinetics and 
product precipitations, but also on the solid contaminants in the precipitated products. 
Solubility of 1-pyrenebutyric acid 
 Solvent 
Ave. 
(M) 
1 2-propanol 0.06 
2 DMF 1.88 
3 DMSO 2.067 
4 THF 0.55 
5 acetonitrile 0 
6 benzene 0 
7 carbon tetrachloride 0 
8 chloroform 0.03 
9 cyclohexane 0 
10 cyclopentane 0 
11 dichloromethane 0.07 
12 diethyl ether 0.02 
13 ethanol 0.06 
14 hexane 0 
15 methanol 0.014 
16 toluene 0 
 
 
Table 7.5 Solubility of 1-pyrenebutryic acid in non-aqueous solvents at room temperature 
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Solubility of phenanthrene-9-carboxaldehyde  
 Solvent Ave. (M) 
1 
1,1,2-
trichlorotrifluoroethane 0.02 
2 2-propanol 0.07 
3 DMF 1.25 
4 DMSO 0.77 
5 THF 1.29 
6 acetonitrile 0.153 
7 benzene 0.66 
8 chloroform 0.04 
9 cyclohexane 0.07 
10 cyclopentane 0.03 
11 dichloromethane 0 
12 diethyl ether 0.1 
13 ethanol 0.1 
14 ethyl acetate 0.44 
15 hexane 0.07 
16 methanol 0.104 
17 toluene 0.14 
 
 
Table 7.6 – Solubility of phenanthrene-9-carboxaldehyde in non-aqueous solvents at room 
temperature. 
 
Solubility of 1-pyrenebutyric acid56 and phenanthrene-9-carboxaldehyde57
 
 was determined in 
several non-aqueous solvents. Both polyaromatic compounds showed very low solubility in 
methanol (Tables 7.3 and 7.4). However they were more soluble in dimethyl sulfoxide (DMSO) 
and tetrahydrofuran (THF). These solvents did solve the solubility issues of reactants; they also 
exhibited increased product solubility [Tables 7.5 & 7.6], though not substantial enough to stop 
product precipitation.  
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Solubility of 27 (Ugi product 176C58) 
 
Solvent Ave. (M) 
1 1,4-dioxane 0.19 
2 1-octanol 0.01 
3 DMF 0.27 
4 DMSO 0.19 
5 THF 0.28 
6 acetonitrile 0.02 
7 benzene 0.03 
8 diethyl ether 0.02 
9 ethanol 0.01 
10 ethyl acetate 0.01 
11 methanol 0.02 
12 toluene 0.03 
 
Table 7.7 Solubility of Ugi product 176C 
 
 
 
 
 
 
 
 
Table 7.8 Solubility of Ugi product 24 (structure inset) 
 
 
Solubility of  24 (Ugi product 150D)59 
 Solvent Ave. (M) 
1 DMSO 0.18 
2 THF 0.49 
3 acetonitrile 0.04 
4 ethanol 0.04 
5 methanol 0.065 
6 toluene 0.04 
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Some reactions involving 1-pyrenebutyric acid 2 were performed in methanol (Schemes 7.2). It 
took almost six days for the acid to dissolve completely. However, it took a week before the 
products started to precipitate out. The products were isolated and analyzed60
methanol; 1 week
R
N
CH3
NH
O
CH3
CH3
CH3
O
N
CH3 CH3
6 (171F/6-4) 7 (171K/11-4)
R =
O
OH
CH3 NH2
CH3
CH3
CH3
N+
C-
RCHO
CH3
8 (173B/14)
1 2
3
4
5
. We believe that, 
though the solubility of the acid was low in methanol, it however got consumed during the 
reaction, and as the dissolved acid was being used the acid concentration in the solution was 
being replenished by constant dissolution in methanol until all of the acid dissolved completely. 
This may have been the reason it took more than week for the solution containing all the 
reactants to clear up before it started forming product precipitate. (Sample 6 took eleven days to 
precipitate the product). Pictures of the reaction mixture in four dram vials were taken 
immediately after all components were mixed in methanol and vortexed for fifteen seconds. The 
solutions were monitored over the days to check for complete dissolution. Pictures were again 
taken whenever a physical change was observed in the reaction mixture.  Pictures of the a set of 
twelve reactions performed (UsefulChem Exp171) have been included (Figures 7.1, 7.2 & 7.3) 
  
Scheme 7.2 – Ugi reaction involving 1-pyrenebutyric acid methanol 
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Figure 7.161 – Reaction mixture of sample 6: Pictures obtained a) immediately after mixing the 
reactants in methanol; b) 8th day c) 11th day. 
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Figure 7.262 – Reaction mixture of sample 7: Pictures obtained a) immediately after mixing the 
reactants in methanol; b) 8th day 
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Figure 7.363
 
 – Picture of the twelve Ugi reactions performed. 
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Table 7.9 – Library of twelve Ugi reactions; UsefulChem Experiment 171 
http://usefulchem.wikispaces.com/Exp171 
V2B 
Rank/Ex
pID 
Solven
t 
Metha
nol 
Aldehyde Amine Acid Isocyanide Ppt (Y/N) & Yield 
1/ 171A 4ml 4,7-dimethoxy-1-naphthaldehyde (216.23mg) 
Methylamine 2M 
methanol soln 
(500uL) 
2,3-dihydroxybenzoic 
acid (154.12mg) 
tosylmethyl 
isocyanide 
(195.24mg) 
Y 
Not a Ugi product 
2/171B 4ml 
2-hydroxy-3-methoxy 
benzaldehyde  
(152.15mg) 
5-methylfurfuryl 
amine (111.4uL) 
Pyrene-1-butyric acid 
(288.34mg);  
t-butylisocyanide 
(113.10uL) N 
3/171C 4ml Phenanthrene-9-carboxaldehyde (206.24mg) 
methylamine 2M 
methanol soln 
(500uL) 
2,4,6-trihydroxybenzoic 
acid (188.13mg) 
tosylmethyl 
isocyanide 
(195.24mg) 
Reactants insoluble in 
methanol at this concentration 
4/171D 4ml 
2-hydroxy-3-methoxy 
benzaldehyde  
(152.15mg) 
Benzylamine 
(109.22uL) 
1-pyrenebutyric acid 
(288.34mg) 
t-butylisocyanide 
(113.10uL) 
Y 
Not a Ugi product 
5/171E 4ml 
2-hydroxy benzaldehyde  
(106.5uL) 
3-chloroaniline 
(105.77uL) 
3,4-methylenedioxy 
phenylacetic acid 
(180.16mg) 
tosylmethyl 
isocyanide 
(195.24mg) 
Reactants not completely 
soluble in methanol at this 
concentration 
6/171F 4ml 
2-naphthaldehyde  
(156.18mg) 
methylamine 2M 
methanol soln 
(500uL) 
Pyrene-1-butyric acid 
(288.34mg) 
t-butylisocyanide 
(113.10uL) 
Y 
Yield : 26% 
7/171G 4ml 
2-naphthaldehyde 
 (156.18mg) 
furfurylamine 
(88.37uL) 
3,4-dihydroxy 
phenylacetic acid 
(168.15mg) 
tosylmethyl 
isocyanide 
(195.24mg) 
N 
8/171H 4ml 
3,5-dimethoxy benzaldehyde 
 (166.17 mg) 
methylamine  
2M methanol 
soln (500uL) 
2,4,6-trihydroxybenzoic 
acid (188.13mg) 
tosylmethyl 
isocyanide 
(195.24mg) 
Y 
Not a Ugi product 
9/171I 4ml 2-hydroxybenzaldehyde (106.5uL) 
Aniline 
(91.1uL) 
3,4-methylenedioxy 
phenylacetic acid 
(180.16mg) 
tosylmethyl 
isocyanide 
(195.24mg) 
N 
10/171J 4ml 
3,4-dihydroxy 
benzaldehyde (138.12mg) 
methylamine 2M 
methanol soln 
(500uL) 
2,4,6-trihydroxybenzoic 
acid (188.13mg) 
tosylmethyl 
isocyanide 
(195.24mg) 
N 
11/171K 4ml 4-(dimethylamino)benzaldehyde (149.19mg) 
methylamine  
2M methanol 
soln (500uL) 
Pyrene-1-butyric acid 
(288.34mg) 
t-butylisocyanide 
(113.10uL) 
Y 
Yield : 53% 
12/171L 4ml Phenanthrene-9-carboxaldehyde (206.24mg) 
methylamine  
2M methanol 
soln (500uL) 
Pyrene-1-butyric acid 
(288.34mg) 
t-butylisocyanide 
(113.10uL) 
Reactants insoluble in 
methanol at this concentration 
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Table 7.10 – Library of twelve Ugi reactions; UsefulChem Experiment 173 
http://usefulchem.wikispaces.com/Exp173 
 
ExpID/ 
VB2Rank 
Solvent 
Methanol Aldehyde Amine Acid Isocyanide Ppt(Y/N) & Yield 
173A/13 4ml 
2-hydroxybenzaldehyde 
(1mmol,106.6uL) 
Aniline 
(1mmol,91.1uL) 
4-
chlorophenylacetic 
acid 
(1mmol,170.6mg) 
Tosylmethylisocyanide 
(1mmol, 195.24mg) 
N 
173B/14 4ml 
4-methylbenzaldehyde 
(1mol,118uL) 
methylamine  2M 
methanol soln 
(1mmol, 500uL) 
1-Pyrenebutanoic 
acid 
(1mmol,288.3mg) 
t-butylisocyanide 
(1mmol,113.1uL) 
Y 
Yield 46% 
173C/15 4ml 
4-(trifluoromethyl)benzaldehyde 
(1mmol,136.5uL) 
methylamine  2M 
methanol soln 
(1mmol, 500uL) 
1-Pyrenebutanoic 
acid 
(1mmol, 288.3mg) 
t-butylisocyanide 
(1mmol, 113.1uL) 
Reactants insoluble 
under the conditions 
173D/16 4ml 
2-hydroxybenzaldehyde 
(1mmol, 106.5uL) 
methylamine  2M 
methanol soln 
(1mmol, 500uL) 
1-Pyrenebutanoic 
acid 
(1mmol, 288.3mg) 
n-Butylisocyanide 
(1mmol,104.5uL) 
Reactants insoluble 
under the conditions 
173E/17 4ml 
3,4-dihydroxybenzaldehyde 
(1mmol, 138.1mg) 
methylamine  2M 
methanol soln 
(1mmol, 500uL) 
Boc-tryptophan 
(1mmol, 304.3mg) 
t-butylisocyanide 
(1mmol, 113.1uL) 
N 
173F/18 4ml 
Phenanthrene-9-carbaldehyde 
(1mmol, 206.2mg) 
Furfurylamine 
(1mmol, 88.3uL) 
2,3-
dihydroxybenzoic 
acid 
(1mmol, 
1)154.1mg 
t-butylisocyanide 
(1mmol, 113.1uL) 
N 
173G/19 4ml 
3,5-dimethoxybenzaldehyde 
(1mmol, 166.2mg) 
Benzylamine 
(1mmol,109.2uL) 
Phenylpropynoic 
acid 
(1mmol, 146.1mg) 
n-Butylisocyanide 
(1mmol, 104.5uL) 
Y 
Yield 44% 
173H/20 4ml 
2-Naphthaldehyde 
(1mmol, 156.2mg) 
5-Methyl 
furfurylamine 
(1mmol,111.5uL) 
3,4-dihydroxy 
phenylacetic acid 
(1mmol, 168.1mg) 
Tosylmethylisocyanide 
(1mmol, 195.2mg) 
N 
 96 
173I/21 4ml 
3-hydroxybenzaldehyde 
(1mmol, 122.1mg) 
methylamine  2M 
methanol soln 
(1mmol, 500uL) 
3,4-dihydroxy 
phenylacetic acid 
(1mmol, 168.1mg) 
tosylmethyl isocyanide 
(1mmol, 195.2mg) 
N 
173J/22 4ml 
3,4-dihydroxybenzaldehyde 
(1mmol, 138.1mg) 
methylamine  2M 
methanol soln 
(1mmol, 500uL) 
1-Pyrenebutanoic 
acid 
(1mmol,288.3mg) 
t-butylisocyanide 
(1mmol, 113.1uL) 
Reactants insoluble 
under the conditions 
173L24 4ml 
3-hydroxybenzaldehyde 
(1mmol, 122.1mg) 
Furfurylamine 
(1mmol, 88.4uL) 
3,4-dihydroxy 
phenylacetic acid 
(1mmol, 168.1mg) 
tosylmethyl isocyanide 
(1mmol, 195.2mg) 
N 
173M/25 4ml 
4-chlorobenzaldehyde 
(1mmol, 140.5mg) 
Furfurylamine 
(1mmol, 88.4uL) 
3,4-dihydroxy 
phenylacetic acid 
(1mmol, 168.1mg) 
tosylmethyl isocyanide 
(1mmol, 195.2mg) 
N 
173N/26 4ml 
2-hydroxy-3-methoxy benzaldehyde 
(o-vanillin) 
(1mmol, 152.1mg) 
2-Chloroaniline 
(1mmol,105.2uL) 
decanoic acid 
(1mmol, 192.9mg) 
tosylmethyl isocyanide 
(1mmol, 195.2mg) 
Waiting Analysis 
173O/27 4ml 
Benzaldehyde 
(1mmol, 101.5uL) 
Furfurylamine 
(1mmol, 88.4uL) 
3,4-dihydroxy 
phenylacetic acid 
(1mmol, 168.1mg) 
tosylmethyl isocyanide 
(1mmol, 195.2mg) 
Y  
Not a Ugi product 
173P/28 4ml 
3-methoxy benzaldehyde 
(1mmol, 121.9uL) 
methylamine  2M 
methanol soln 
(1mmol, 500uL) 
1-Pyrenebutanoic 
acid 
(1mmol,288.3mg) 
t-butylisocyanide 
(1mmol, 113.1uL) 
Reactants insoluble 
under the conditions 
173Q/29 4ml 
4-methylbenzaldehyde 
(1mmol, 118uL) 
Furfurylamine 
(1mmol, 88.4uL) 
3,4-dihydroxy 
phenylacetic acid 
(1mmol, 168.1mg) 
tosylmethyl isocyanide 
(1mmol, 195.2mg) 
N 
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Figure 7.464 – Reaction mixtures of sample 865: Pictures obtained a) immediately after mixing 
the reactants in methanol; b) 5th day c) 7th day. 
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Scheme 7.3 – Ugi reaction involving 3, 5-dimethoxybenzaldehyde (10), methylamine (11), 2, 4, 
6-trihydroxybenzoicacid (9) and tosylmethyl isocyanide (12) in methanol 
 
Since one of the objectives of this research project was to identify conditions required during the 
Ugi reaction in order to selectively precipitate out the Ugi product. Therefore it was important 
that before a product precipitated out during a reaction, the reactants had to be completely 
dissolved in the solvent. Some of the reactants did not dissolve immediately after mixing them 
together, like the previously mentioned cases involving 1-pyrenebutyric acid; however they 
formed the Ugi product. In some cases, though all reactants dissolved completely soon after 
mixing and formed precipitates after some time, it did not correspond to the Ugi product. One 
such case was the reaction involving 3, 5-dimethoxybenzaldehyde, methylamine, 2, 4, 6-
trihydroxybenzoicacid and tosyl methylisocyanide (12)66 [scheme 7.3]. Immediately after mixing 
the reactant in methanol a clear precipitate was obtained. A white powder 14 precipitated out 
after eight days. 
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Figure 7.5 – Sample 1367: Pictures obtained a) immediately after mixing the reactants in 
methanol; b) 8th day. 
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Figure 7.6 – Sample 14: Isolated imminium carboxylate salt – MW- 349 daltons. 
 
 
Figure 7.7 – Mass spectrum of sample 14  
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Figure 7.8 – HNMR of sample 14 
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Figure 7.9 – HNMR of p-toluenesulfonylsulfonylmethyl isocyanide (TOSMIC) 12 
 
 
Sample 14 was only slightly soluble in deuterated chloroform, deuterated acetone, deuterated 
water and deuterated benzene. However it was readily soluble in deuterated dimethyl sulfoxide 
(DMSO-d6). Mass spectrum (Fig 7.5) clearly indicated the presence of the imminium salt 
(M+H= 349.34). Proton NMR (Fig 7.6) supported mass spectrum. All peaks corresponding to 
the salt were identified. Significantly absent from the NMR were peaks corresponding to p-
touenesulfonylmethyl isocyanide. A proton NMR of the isocyanide (7.7) shows two doublets 
of doublets between 7.2 and 8.0 ppm along with a methylene at 4.8ppm. These peaks were 
missing in the NMR of sample 14. The spectrum also indicates the presence of a dimethoxy 
[6H at 3.72 ppm], suggesting the presence of 3, 5-dimethoxybenzene in the product. The 
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HNMR shows a 3H labile peak at 8.95ppm indicating the presence of the trihydroxyphenyyl 
component in the product. A 3H methyl peak is also seen at 3.36ppm, possibly from methyl 
amine. Off the four components the one missing was tosylmethyl isocyanide. Tosyl ring 
should have given two clear doublet of doublet in the aromatic region. Therefore the HNMR 
ruled out the possibility of the Ugi product in the sample. 
 
Figure 7.10 – CNMR of sample 14 
 
C-NMR - Only thirteen peaks were seen, confirming an absence of tosylmethyl group. 
Based on the information obtained from IR, HNMR, CNMR and FAB-MS; a structure of an 
imminium benzoate (Fig7.5) was assigned to 14.  
Yet another trend observed was that compounds contained phenolic and alcoholic systems did 
not formed precipitates. Aldehdyes such as 2-hydroxybenzaldehyde (21 reactions), 3-
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hydroxybenzaldehyde (6 reactions), 3,4-dihydroxybenzaldehyde, (15 reactions), 4-
hydroxybenzaldehyde (2 reactions) and  2-hydroxy-3-methoxybenzaldehyde (14 reactions) did 
not form any precipitate Ugi products. 
Similarly carboxylic acids containing a phenolic or an alcoholic functional group did not 
precipitate Ugi products. Some of the carboxylic acids containing phenolic / alcoholic 
functional groups included 2,3-dihydroxybenzoic acid (6 reactions), 2,4,6-trihydroxybenzoic 
acid (17 reactions), 2,6-dihydroxybenzoic acid (2 reactions), 3,5-dihydroxybenzoic acid (2 
reactions), D-(−)-quinic acid (5 reactions) and salicylic acid (1 reaction).  
7.6 – Solvent effects 
Most Ugi reactions are often carried out in methanol. It is often debated that the hydrogen 
bonding and polarity of the solvent plays a vital role in the reaction68
However as mentioned previously, methanol was a poor solvent for polyaromatic compounds, 
phenanthrene-9-carboxaldehyde and 1-pyrenebutyric acid. Substitute solvent, THF was 
therefore used for these reactions because it exhibited substantially higher solubility for these 
polyaromatics than methanol. Apart from THF, DMSO also exhibited high solubility for the 
reactants; however it also showed high product solubility. DMSO also has a high boiling 
. High concentration of 
reactants favors the Ugi reaction. Hence methanol was the solvent of choice for most Ugi 
reactions carried out in our lab, not only because of above mentioned facts, but also as it 
provided optimum solubility for reactants. Enhanced solubility of the reactants appears 
appropriate considering the hydrogen bonding capacity and the polarity of the solvent and the 
polar nature of the functional groups of the reactants. Several Ugi products were synthesized 
using methanol as solvent. Reaction schemes and spectral data are included in the 
experimental section.  
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point, which renders it difficult to remove from the product by evaporation. Hence DMSO was 
discarded as the Ugi solvent in favor of THF. 
Reactants which were not very soluble in methanol like phenanthrenen-9-carboxaldehyde 
dissolved in THF. Some Ugi reactions carried out in THF yielded solid products. Few 
reactions mixtures were left in a refrigerator before the product precipitated out. One such 
reaction which yielded a solid product involved phenanthrene-9-carboxaldehyde, 
benzylamine, 4-chloro phenylacetic acid and n-butylisocyanide (Scheme 7.4)69
 
. In general 
methanol was a more suitable solvent for the Ugi reaction than was THF or any other.  
 
 
 
Scheme 7.4 – Ugi reaction involving phenanthrene-9-carboxaldeyde, benzylamine, 4-
chlorophenylacetic acid and n-butylisocyanide in THF yielded 19. 
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Figure 7.11 – Solvent trends 
7.7 Anti-malarial activity:   
Anti-malarial activity tests were conducted by the Rosenthal group at UCSF.  The Ugi 
products were tested against falcipain-2 and Plasmodium falciparum cell as well. 
Many compounds that were sent exhibited some amount of anti-malarial activity. Compound 
19 (UsefulChem ID - UC175C) was one of the best from the results received (Table 7.11). 
 
Figure 7.12 – Sample 19 from UsefulChem Exp 175 (UC175C) was found to exhibit anti-
malarial activity.   
 107 
 
Details of the testing results are listed in the table below. This was obtained from the 
Rosenthal group. 
Table 7.11 Anti-malarial activity results obtained from the Rosenthal group at UCSF. 
Sample ID 
(UsefulChem ID) 
Recombinant 
FP-2 
Fluoroscan IC 
50 (nM) SD 
P. falciparum 
strain W2  In 
Vitro IC 50 (nM) 
Flow SD 
Enzyme 
target 
25 (148B) 19655 1874 7,994.00 733 falcipain-2 
24 (150D) 16660 2319 5,411.00 241 falcipain-2 
19 (175C) 6621 21 1,838.67 156.98 falcipain-2 
27 (176C) 8419 108 4,852.67 170.41 falcipain-2 
6 (171F/6-4) 12752 4325 ~10000   falcipain-2 
7 (171K/11-4) 13170 1966 >10000   falcipain-2 
8 (173B/14) 15330 3267 ~10000   falcipain-2 
21 (173G19-4) 50000   >10000   falcipain-2 
174K 12355 1110 ~10000   falcipain-2 
187-2A >50000   >10000   none 
86B 50000   >10000   none 
62E >50000   >10000   none 
104C >50000   >10000   none 
64C >50000   >10000   none 
99C >50000   >10000   none 
108C >50000   >10000   none 
109C >50000   >10000   none 
 
 Compounds 150C and 148B (Table 5.11) were found to be inhibitors of cystein protease 
enzyme falcipain-2, roughly two orders of magnitude of enzyme inhibitory activity lower than 
the Rosenthal positive control E6470
Conclusions: Ugi reactions in which all components are dissolve freely are more likely to form 
precipitates when performed in methanol. Aldehydes which were more likely to form Ugi 
. Both compounds IC-50s ranged between 4.7-19.7 
micromolar. However when these compounds were tested against the parasite cell, they did 
not exhibit ‘food vacuole abnormality’, which would be indicative of cystein protease 
inhibition. This suggests a different pathway along which these compounds show the desired 
anti-malarial activity.  
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products precipitates included benzaldehyde, phenanthrene-9-carboxaldehyde, 4-
(trifluoromethy) benzaldehyde, piperonal and veratraldehyde. In terms of carboxylic acids, 
boc-glycine, crotonic acid and phenyl acetic acid were more likely to form Ugi product 
precipitates. With respect to isocyanides the propensity of Ugi product precipitation followed 
cyclohexyl isocyanide > t-butyl isocyanide > n-butyl isocyanide > benzyl isocyanide. 
Reactions which contained polyaromatic components must be preferentially carried out in 
THF than in methanol. Some of the compounds synthesized also exhibited anti-malarial 
activity.  
 
 
7.8 Experimental 
General Procedure: To four dram vials and charged with methanol (4 ml), the four reactants 
[aldehyde, amine, carboxylic acid and isocyanide] (1mmol each) were added to each in that 
order. After each addition, the resulting solution was vortexed for 15 seconds (or more) and 
confirmed that a homogeneous solution had been obtained. The vials were capped tight and 
left at room temperature. After crystallization, each solution was decanted and the crystals 
were washed with methanol (3x 500uL) and dried under vacuum.  
Note: The above procedure was followed for the synthesis of the compounds listed below. 
Whenever a different procedure was used, it is listed before the characterization data. 
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Scheme 7.5 Reaction scheme for the formation of Compound 20 (UsefulChem ID- 171F/6-4) 
 
Compound 6: N-[2-(tert-butylamino)-1-(2-naphthyl)-2-oxo-ethyl]-N-methyl-4-pyren-1-yl-
butanamide; C37H36N2O2; White solid; M.Pt: 155-157 C; 1H NMR (  ppm, CDCl3) 1.37 (s, 9H), 
2.79 (s, 3H), 2.19 (m, 2H), 2.44 (m, 2H), 3.34 (m, 2H), 5.95 (bs, 1H) 6.49 (s,1H), 7.30-8.45 
(aromatics, 16H) 13C NMR (  ppm, CDCl3) ppm, 26.6, 28.6, 32.4, 32.6, 32.9, 51.6, 60.4, 123.3, 
124.5, 124.66, 124.68, 124.8, 124.9, 125.6, 126.3, 126.41, 126.48, 126.5, 127.1, 127.2, 127.3, 
127.4, 127.9, 128.3, 128.4, 128.6, 129.7, 130.7, 131.2, 132.7,133.0, 133.2, 136.0, 169.1, 173.5 ; 
HRMS (FAB,m-nitrobenzyl alcohol): m/z calcd for C37H37N2O2 541.28550 [M+H] found 
541.2856;  yield 26%, 139mg. 
 
 
 
 
Note: All spectra for compound 6can be found on the UsefulChem Wiki Exp171; (Sample ID- 
171F/6-4); http://usefulchem.wikispaces.com/Exp171  
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Fig 7.13 – HNMR of Compound 6  
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Fig 7.14 – CNMR of compound 6 
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Fig 7.15 – HRMS for Compound 6 
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Scheme 7.6 – Ugi reaction leading to the formation of compound 7 
 
Compound 7: N-[2-(tert-butylamino)-1-(4-dimethylaminophenyl)-2-oxo-ethyl]-N-methyl-4-pyren-
1-yl-butanamide; C35H39N3O2; White solid; M.Pt: 193-195 C; 1H NMR (  ppm, CDCl3) 1.35 (s, 
9H), 2.25 (m, 2H), 2.47 (m, 2H), 2.76 (s, 3H), 2.92 (s, 6H), 3.42 (m, 2H), 5.55 (bs 1H, Labile), 6.18 
(s, 1H), 6.66 (d, 2H, J = 8.8 Hz), 7.19 (d, 2H , J = 8.8 Hz), 7.77-8.40 (pyrenyl Aromatics, 9H); 13C 
NMR (  ppm, CDCl3) ppm, 26.6, 28.6, 32.1, 32.6, 33.0, 40.2, 51.4, 60.1, 112.2, 123.4, 124.5, 
124.64, 124.66, 124.8, 124.9, 125.6, 126.4, 127.1, 127.30, 127.37, 128.6, 129.6, 130.1, 130.8, 
131.2, 136.2, 149.9, 169.7, 173.1 ; HRMS (FAB; m-nitrobenzyl alcohol): m/z calcd for 
C35H39N3O2Na 556.2939 [M+Na] found 556.2935; yield 53% , 283mg. 
 
 
 
 
Note: All spectra for compound 7 can be found on the UsefulChem Wiki Exp171; (Sample ID- 
171K/11-4); http://usefulchem.wikispaces.com/Exp171  
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Fig 7.16 – HNMR of Compound 7 
 
 
 
 
 
Fig 7.17 – CNMR of Compound 7 
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Fig 7.18 – HRMS of Compound 7 
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Scheme 7.7 – Reaction Scheme for the synthesis of Compound 19  
 
Compound 19: 2-[benzyl-[2-(4-chlorophenyl)acetyl]amino]-N-butyl-2-(9-phenanthryl) acetamide: 
Equimolar amounts of aldehyde, amine, carboxylic acid and an isocyanide was dissolved in THF in 
glass vials and vortexed to dissolve them. Addition of the components to THF followed the 
sequence aldehyde, amine, carboxylic acid and isocyanide. After component was added the vials 
was vortexed to obtain homogenous solution. Vials were left undisturbed for four days; a picture 
was obtained each day to check if a solid precipitate had formed in them. The solid precipitate (if 
formed) was then washed with hot methanol (2-3mL) and the residue collected after filtration was 
dried in a disiccator. The product was analyzed by HNMR and HRMS.  
C35H33ClN2O2; 1H NMR (  ppm, CDCl3) 0.88 (t, 3H J 7.3Hz),1.24-1.32 (m, 2H), 1.4-1.5 (m, 2H), 
3.2-3.32 (m, 1H), 3.36-3.47(m, 1H), 3.52-3.72 (m, 2H), 4.66-4.82 (m, 2H), 5.82 (t, 1H J 5.6Hz), 
6.6-6.68 (m, 2H), 6.72-6.9 (m, 3H), 7.07 (d, 2H J 8.3Hz), 7.11 (s, 1H), 7.23 (d, 2H, J 8.3Hz), 7.52-
7.59 (m, 1H), 7.6-7.71 (m, 3H), 7.78 (d, 1H J 7.3Hz), 7.87 (s, 1H), 8.09 (d, 1H, J 7.8Hz), 8.57 (d, 
1H, J 8.3Hz), 8.63 (d, 1H, J 7.8Hz). Yield 30.2%, 332mg. 
Note: All spectra for compound 19 can be found on the UsefulChem Wiki Exp215; (Sample ID-
UCExp215F-2); http://usefulchem.wikispaces.com/Exp215 
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Figure 7.19 – HNMR of Compound 19 
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Figure 7.20 – HRMS of Compound 19 
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Scheme 7.8 - Reaction scheme for the formation of compound 21 (UsefulChem ID 173G19-4) 
 
Compound 21:  N-benzyl-N-[2-butylamino-1-(3,5-dimethoxyphenyl)-2-oxo-ethyl]-3-p henyl-
prop-2-ynamide: C30H32N2O4; White solid; M.Pt-137-139C; 1H NMR ( ppm, 500MHz, CDCl3); 
listed NMR peaks are common to both rotamers (E, Z) unless otherwise stated; rotamers are 
denoted by major and minor and are present in a 3:1 ratio at rt) 0.79 (t, 3H, J=7.3 Hz, minor), 0.88 
(t, 3H, J= 7.3Hz, major), 1.13-1.23 (m, 2H, minor), 1.24-1.33 (m, 2H, major), 1.37-1.50 (m, 2H), 
3.12-1.24 (m, 1H), 3.23-3.34 (m, 1H), 3.65 (s, 6H, major), 3.66 (s, 6H, minor), 4.59 (d, 1H, J= 
15.1Hz, minor), 4.66 (d, 1H, J= 15.1Hz, minor), 4.78 (d, 1H, J= 16.6 Hz, major), 5.14 (d, 1H, J= 
16.6 Hz, major), 5.68 (s, 1H, major), 5.97 (t, 1H, J= 5.8Hz, minor), 6.04 (t, 1H, J= 5.8Hz, major), 
6.12 (s, 1H, minor), 6.29-6.34 (m, 1H, major), 6.35-6.37 (m, 1H, minor), 6.40 (d, 1H, J=2.4Hz), 
minor),6.43 (d, 1H, J=2.4Hz, major), 7.09 (dd, 1H, J= 7.8, 1.4Hz), 7.14-7.23 (m, 5H), 7.24-7.31 
(m, 2H), 7.32-7.48 (m, 2H), 7.56 (d,H, J= 7.8Hz); 13C NMR ( ppm, CDCl3 / CD3OD) 13.11(minor), 
13.17(major), 19.60, 30.79(major), 30.85(minor), 39.01(major), 39.06(minor), 47.26, 51.45, 
54.87(major), 54.91(minor),  62.25(major), 66.32(minor), 80.80(minor), 81.39(major), 
91.40(major), 92.70(minor), 100.50(minor), 100.55(major), 107.54(major), 107.60(minor), 
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119.50(minor), 119.53(major), 126.55(major), 126.65(minor), 127.34, 127.71(minor),  
127.78(major), 128.16(major), 128.27(minor),  130.06(major), 130.25(minor), 132.08(major),  
132.23(minor), 135.50(major), 135.54(minor),  137.10(major), 137.50(minor), 156.16(minor),  
156.29(major), 160.44(major), 160.56(minor) 168.78(major), 168.95(minor). HRMS (FAB, m-
nitrobenzyl alcohol): m/z calcd for C30H32N2O4Na [M+Na] 507.2259, found 507.2247; yield 44%, 
213mg. 
 
 
 
Fig 7.21 – HNMR of Compound 21 
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Note: All spectra for compound 21can be found on the UsefulChem Wiki Exp173; (Sample ID- 
173G19-4); http://usefulchem.wikispaces.com/Exp173  
 
 
 
 
 
 
Fig 7.22 – CNMR of Compound 21 
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Fig 7.23 – HRMS of Compound 21 
 
 
Scheme 7.9:  Compound 21: Rotamers 
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Scheme 7.10 Synthesis of the Ugi product 22 in methanol71
Compound 22 : tert-butyl (2-{[2-(tert-butylamino)-2-oxo-1-phenylethyl][(5-methylfuran-2-
yl)methyl]amino}-2-oxoethyl)carbamate: 
 
A solution of benzaldehyde (212 uL, 2 mmol) and 5-methylfurfurylamine (244 uL, 2.2 mmol) 
was made in methanol in a 4mL volumetric flask. The reaction mixture was allowed to sit for 
about 6 hours without stirring to form the imine. A solution of Boc-Gly-OH (350 mg, 2 mmol), 
and tert-butyl isocyanide (226 uL, 2 mmol) was made up in 4 ml volumetric flask in methanol. 
This solution was added to the preformed Imine solution. The reaction mixture was allowed to sit 
undisturbed overnight, when a crystalline Ugi product was obtained which was filtered and 
washed with cold methanol.  
C25H35N3O5: 1H NMR (  ppm, CDCl3) 1.32 (s, 9H),1.44 (s, 9H), 2.13 (s, 3H), 4.15-4.22 (m, 2H), 
4.35-4.55 (m, 2H), 5.4-6.0 (m, 5H), 7.2-7.4 (m, 5H, phenyl); 13C NMR (  ppm, CDCl3) 13.3, 
28.2, 28.4, 42.4, 42.7, 51.4, 62.9, 79.3, 106.1, 108.6, 128.2, 128.4, 129.6, 134.7, 147.6, 151.5, 
155.5, 168.3, 170.0; HRMS (FAB,m-nitrobenzyl alcohol): m/z calcd for C25H36N3O5 [M+H] 
458.2649, found 458.2648. Yield 38%, 348.8mg. 
Note: All spectra for compound 22 can be found on the UsefulChem Wiki Exp086; (Sample ID- 
UCExp086B); http://usefulchem.wikispaces.com/Exp086  
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Fig 7.24 – HNMR of Compound 22 
 
 
 
 
Fig 7.25 - CNMR of Compound 22 
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Fig 7.26 -  HRMS of Compound 22 
 
Fig 7.27 – X-Ray Crystal Structure of Compound 22 
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Scheme 7.11 – Reaction scheme for the formation of the Ugi product 23 
 
Compound 23 :N-[2-(tert-butylamino)-2-oxo-1-(p-tolyl)ethyl]-N-methyl-4-pyren-1-yl-
butanamide: C34H36N2O2; White solid; M.Pt- 140-142C; 1H NMR (  ppm, 500MHz, CDCl3) 
1.35 (s, 9H), 2.16-2.28 (m, 2H), 2.30 (s, 3H), 2.36-2.45 (m, 1H), (2.46-2.60 (m, 1H), 2.76 (s, 
3H), 3.38 (ddd, 2H J=9.3, 6.5, 7.5Hz), 5.71 (bs, 1H), 6.24 (s, 1H), 7.14 (d, 2H, J=8.0Hz), 7.21 (d, 
2H, J=8.0Hz), 7.82 (d, 1H, J=7.7Hz), 7.90-8.20 (m, 7H), 8.30 (d, 1H, J=9.3Hz); 13C NMR (  
ppm, CDCl3) 20.8, 26.5, 28.5, 32.2, 32.5, 32.8, 51.3, 60.1, 123.2, 124.4, 124.5, 124.7, 124.8, 
125.5, 126.3, 127.0, 127.1, 127.2, 128.5, 128.9, 129,2, 129.6, 130.6, 131.1, 132.7, 136.0, 137.7, 
169.3, 173.2; HRMS (FAB,m-nitrobenzyl alcohol): m/z calcd for C34H36N2O2Na [M+Na] 
527.2674 found 527.2667; yield 46%, 232mg. 
 
 
Note: All spectra for compound 23 can be found on the UsefulChem Wiki Exp173; (Sample ID- 
173B/14-4); http://usefulchem.wikispaces.com/Exp173 
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Figure 7.28 –HNMR of Compound 23 
 
 
 
Figure 7.29 – CNMR of Compound 23 
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Figure 7.30 –HRMS of Compound 23 
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Compound 24: (E)-N-benzyl-N-[2-(tert-butylamino)-2-oxo-1-(9-phenanthryl)ethyl]but-2-
enamide. 
To a one dram vial, charged with methanol (1 ml), benzylamine, phenanthrene-9-
carboxaldehyde, crotonic acid and tert-butyl isonitrile (0.5mmol each) was added in that order. 
After each addition, the resulting solution was vortexed for 15 seconds (or more) and confirmed 
that a homogeneous solution had been obtained. The vial was capped tight and left at room 
temperature. After crystallization, the solution was decanted and the crystals were washed with 
methanol (3x 500uL) and dried under vacuum to obtain compound 24.  
C31H32N2O2: White powder; H-NMR (  ppm ppm, CDCl3) 1.39 (s, 9H), 1.77 (d, 3H J=6.3Hz), 
4.79 (d, 1H, J=17.9 Hz), 4.88 (d, 1H, J=17.9 Hz), 5.67 (s, 1H), 6.18 (d, 1H, J=15.0 Hz), 6.33-
6.81 (m, 4H), 6.88-7.23 (m 2H ), 7.36-7.74 (m, 4H), 7.80 (d,1H J=7.3 Hz), 7.90 (s 1H), 8.09 (d 
1H J 12.2 Hz), 8.51 (t 2H J=12.8Hz); 13C NMR (  ppm, CDCl3) 18.1, 28.6, 49.0, 50.6, 51.7, 57.6, 
94.6, 122.2, 122.4, 122.9, 124.2, 125.8, 126.6, 126.68, 127.1, 127.2, 128.7, 129.3, 130.1, 130.2, 
130.4, 130.7, 30.9, 137.3, 143.4, 168.0, 169.9 ; IR (KBr, Ʋmax cm-1) 3323, 3058, 2969, 1677, 
1655, 1594, 1526, 1421, 722, 695; HRMS m/z calcd for C31H33N2O2 : 465.2542 [M+H] found 
465.2448; C31H32N2O2Na 487.23614 [M+Na] found 487.23761. Yield 58.3%, 135.8mg. 
Note: All spectra for compound 24 can be found on the UsefulChem Wiki Exp150; (Sample ID- 
150D); http://usefulchem.wikispaces.com/Exp150 
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Figure 7.31 – HNMR of Compound 24 
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Figure 7.32 – CNMR of Compound 24 
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Figure 7.33 – HRMS of Compound 24 
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Figure 7.34 – X-ray Crystal structure of Compound 24 
 
Compound 25: (E)-N-[2-(tert-butylamino)-2-oxo-1-(9-phenanthryl)ethyl]-N-heptyl-but-2-
enamide 
To a one dram vial, charged with methanol (1mL) heptylamine, phenanthrene-9-carboxaldehyde, 
crotonic acid and tert-butyl isonitrile (0.5mmol each) was added in that order. After each 
addition, the resulting solution was vortexed for 15 seconds (or more) and confirmed that a 
homogeneous solution had been obtained. The vial was capped tight and left at room temperature 
for 3 days. The solution formed solid upon moving it to another spot. The obtained solid was 
washed with methanol (3 x 500uL), centrifuged each time to obtain a white residue. The wet 
product was set under a high vac to remove the solvent. 
C31H40N2O2: White powder; M.pt~ 179-181C; 1H-NMR (  ppm, CDCl3) 0.30 (m, 1H), 0.54-0.95 
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(m, 10H), 1.05-1.2 (m, 1H ), 1.39 (s, 9H), 1.89 (d, 3H J 6.8Hz), 2.86 (bs, 1H), 3.28-3.60 (m 2H ), 
5.79 (s,1H), 6.24 (d,1H J 15Hz), 6.87 (s 1H), 7.0-7.15 (m 1H), 7.56-7.76 (m 4H), 7.88 (d 1H J 
7.85 Hz), 7.92-8.04 (m 2H), 8.68 (d 1H J 8.25 Hz), 8.73 (d 1H J 8.25Hz); 13C NMR (  ppm, 
CDCl3) 13.8, 18.2, 22.1, 26.2, 27.9, 28.6, 29.9, 31.0, 45.5, 51.7, 57.8, 122.0, 122.4, 123.1, 124.1, 
126.8, 126.9, 127.43, 127.48, 128.9, 129.15, 129.16, 130.3, 130.47, 130.9, 131.0, 142.7, 166.9, 
169.9; IR (KBr, 1/cm): v=3315, 3080, 2926, 2855, 1663, 1614, 1452, 1419, 748, 728; HRMS 
m/z calcd for C31H40N2O2Na: 495.298748 [M+Na]; found 495.2997. Yield 50.1%, 118.5mg. 
Note: All spectra for compound 25 can be found on the UsefulChem Wiki Exp148; (Sample ID- 
148B); http://usefulchem.wikispaces.com/Exp148 
 
Figure 7.35 – HNMR of Compound 25 
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Figure 7.36 – CNMR of Compound 25 
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Figure 7.37 – HRMS of Compound 25 
Compound 26: 2-[benzyl-[2-(4-chlorophenyl)acetyl]amino]-N-butyl-2-(9-phenanthr
yl)acetamide 
To a one dram vial, charged with methanol (1mL) and benzylamine, phenanthrene-9-
carboxaldehyde, 4-chlorophenyl acetic acid and n-butyl isocyanide (0.5mmol each) was added in 
that order. After each addition, the resulting solution was vortexed for at least 15 seconds and 
confirmed that a homogeneous solution had been obtained. The vial was capped tight and left at 
room temperature for 1 day. 
 137 
 
C35H33ClN2O2; White solid; 1H NMR (  ppm, 500MHz, CDCl3); 0.86 (t, 3H, J=7.3Hz), 1.04-
1.32 (m, 2H), 1.33-1.47 (m, 2H), 3.04-3.27 (m, 1H), 3.29-3.46 (m, 1H), 3.51 (d, 1H, J=16.1Hz), 
3.60 (d, 1H, J=16.1Hz), 4.73 (d, 1H, J=17.5Hz), 4.75 (d, 1H, J=17.5Hz), 6.14 (t, 1H, J=5.8Hz), 
6.61 (s, 1H), 6.62 (s, 1H), 6.70-6.79 (m, 2H), 6.80-6.87 (m, 1H), 6.97 (d, 2H, J=8.3Hz), 7.14 (s, 
1H), 7.16 (d, 2H, J=8.3Hz), 7.48-7.72 (m, 4H), 7.78 (d, 1H, J= 7.8Hz), 7.87 (s, 1H), 8.10 (d, 1H, 
J=7.8Hz), 8.55 (d, 1H, J=8.3Hz), 8.62 (d, 1H, J=7.8Hz) HRMS m/z calcd for C35H34ClN2O2 
549.23031[M+H]; found 549.2293. Yield 71.7%, 198mg. 
Note: All spectra for compound 26 can be found on the UsefulChem Wiki Exp175; (Sample ID- 
175D); http://usefulchem.wikispaces.com/Exp175 
 
Figure 7.38 – HNMR of Compound 26 
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Figure 7.39 – HRMS of Compound 26 
 
Compound 27: N-butyl-2-[2-furylmethyl-(2-phenylacetyl)amino]-2-(9-phenanthryl)acetamide 
 To a one dram screw-cap vial was added methanol (1 mL), furfurylamine (44.2uL, 0.5 mmol) 
phenanthrene-9-carboxaldehyde (103.1 mg, 0.5 mmol), phenylacetic acid (68.08 mg, 0.5 mmol) 
then n-butyl isocyanide (52.28 uL, 0.5 mmol). After each addition, a homogeneous solution was 
obtained following vortexing for at least 15 s. The vial was capped and left at room temperature 
for 22 h. At this point a precipitate was observed. Methanol (1 mL) was then added followed by 
 139 
20 s of vortexing and 5 min of centrifugation. The supernatant was discarded and the washing 
procedure was repeated twice. The resulting solid was left to dry under vacuum.  
C33H32N2O3: White solid; 1H NMR (  ppm, CDCl3) 0.89 (t, 3H, J=7.3Hz), 1.22-1.39 (m, 2H), 
1.4-1.5 (m, 2H), 3.18-3.31 (m, 1H), 3.32-3.44 (m, 1H), 3.93-4.02 (m, 2H), 4.54 (d, 1H, 
J=17.5Hz), 4.67 (d, 1H, J=17.5Hz), 4.90 (d, 1H, J=2.9Hz), 5.58-5.68 (m, 1H), 5.95 (t, 1H, J= 
5.8Hz),6.76-6.83 (m, 1H), 6.95 (s, 1H), 7.17-7.37 (m, 5H), 7.44-7.52 (m, 1H), 7.56-7.63 (m, 
2H), 7.64-7.72 (m, 1H), 7.77-7.87 (m, 2H), 7.89 (s, 1H), 8.63 (d, 2H, J=8.3Hz) ; HRMS 
(FAB,m-nitrobenzyl alcohol): m/z calcd for C33H33N2O3 [M+H] 505.2491 found 505.2450; yield 
62%, 156.5mg. 
Note: All spectra for compound 27 can be found on the UsefulChem Wiki Exp176; (Sample ID- 
176CD); http://usefulchem.wikispaces.com/Exp176 
 
Figure 7.40 – HNMR of Compound 27 
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Figure 7.41 – CNMR of Compound 27 
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Figure 7.42 – HRMS of Compound 27 
 
Compound 28: N-[2-(cyclohexylamino)-1-(4-dimethylaminophenyl)-2-oxo-ethyl]-N,3-
dimethyl-benzamide: C25H33N3O2; White solid; 1H NMR ( ppm, 500MHz, CDCl3) 0.9-1.2 (m, 
3H), 1.3-1.45 (m, 2H), 1.5-1.75 (m, 3H), 1.85-2.0 (m, 2H), 2.35 (s, 3H), 2.79 (s, 3H), 2.97 (s, 
6H) 3.8-3.9 (m, 1H), 5.2-5.4 (m, 1H), 5.88 (bs, 1H), 6.25 (s, 1H), 6.6-6.8 (m, 2H), 7.1-7.4 (m, 
5H); 13C NMR (  ppm, CDCl3) 21.2, 24.6,25.3, 32.8, 34.6, 40.2, 48.3, 60.1, 112.1, 122.0, 123.8, 
127.5, 127.9, 130.0, 130.4, 136.3, 137.9, 150.1, 168.8, 172.1;HRMS (FAB): m/z calcd for 
C25H33N3O22Na [M+Na] 430.247047 found 430.245077 ; yield 18%, 291mg. 
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Note: All spectra for compound 28 can be found on the UsefulChem Wiki Exp216; (Sample ID- 
216-10); http://usefulchem.wikispaces.com/Exp216 
 
 
 
Figure 7.43 – HNMR of Compound 28 
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Figure 7.44 – CNMR of Compound 28 
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Figure 7.45 – HRMS of Compound 28 
 
 
Compound 29: N-butyl-2-[(2-methoxyacetyl)-[(5-methyl-2-furyl)methyl]amino]-2-[4-
(trifluoromethyl)phenyl]acetamide; C22H27F3N2O4; 1H NMR (  ppm, CDCl3) 0.903 (t, 3H J 
7.3Hz),1.24-1.36 (m, 2H), 1.4-1.5 (m, 2H), 2.13 (s, 3H), 3.15-3.32 (m, 2H), 3.47 (s, 3H), 4.33 (s, 
2H), 4.2-4.6 (m, 2H), 5.73 (s, 2H), 5.89 (s, 1H), 6.23 (bs, 1H), 7.4(d, 2H, J 8Hz) 7.53 (m, 2H,); 
13C NMR (  ppm, CDCl3) ppm, 13.3, 13.6, 19.9, 31.3, 39.5, 42.9, 59.2, 62.2, 71.4, 106.3, 109.4, 
125.2, 125.3, 129.5, 130.1(q), 138.9, 147.5, 151.9, 168.5, 170.6; yield 7%, 31mg. 
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Note: All spectra for compound 29 can be found on the UsefulChem Wiki Exp231; (Sample ID- 
231-4A); http://usefulchem.wikispaces.com/Exp231 
 
 
 
 
 
Figure 7.46 – HNMR of Compound 29 
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Figure 7.47 – CNMR of Compound 29 
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Figure 7.48 – DEPT of Compound 29 
 
 
Compound 30: tert-Butyl {2-[{2-(tert-butylamino)-2-oxo-1-[4-(trifluoromet
hyl)phenyl]ethyl}(2-furylmethyl)amino]-2-oxoethyl}carbamate 
Synthetic procedure:  A 1M per component solution of 4-(trifluoromethyl) benzaldehyde 
(4mmol, 546.2uL), furfuryl amine (4mmol, 353.5uL), boc-glycine(700.7 mg, 4mmol), and an 
isocyanide (4 mmol) was made-up in a caluclated volume of methanol. Once a solid product was 
obtained, it was filtered and washed with methanol. The product was vacuum dried. 
C25H32F3N3O5 :White solid; m.p. 172-174C;1H NMR (500MHz,  ppm, CDCl3) 1.33 (s, 9H), 1.44 
(s, 9H), 4.23 (m, 2H), 4.49 (d, J=17.5Hz, 1H), 4.58 (d, J=17.5Hz, 1H), 5.42 (s, 1H), 5.71 (s, 1H), 
5.91(s, 1H), 5.94 (s, 1H), 6.11 (s, 1H), 7.19 (s, 1H), phenyl 7.36 (d, J= 8.2 Hz, 2H), 7.50 (d, 
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J=8.2Hz, 2H); 13C NMR ; (500MHz, ppm, CDCl3) 28.25, 28.47, 42.62, 42.77, 51.77, 62.24, 
79.66, 108.11, 110.47, 121.96, 125.30, 125.82, 129.57, 138.94, 142.04, 149.66, 155.66, 167.69, 
170.36 ; IR (Ʋmax cm-1 ATR): 1650,1672,1697, 2969, 3329; HRMS (FAB): m/z calcd for 
C25H32F3N3O5Na [M+Na] 534.21918 found 534.2200. Yield 62.4%, 1.278g. 
 
Note: All spectra for compound 30 can be found on the UsefulChem Wiki Exp235; (Sample ID- 
235-1A); http://usefulchem.wikispaces.com/Exp235 
 
 
Figure 7.49 – HNMR of Compound 30 
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Figure 7.50 – CNMR of Compound 30 
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Figure 7.51 – HRMS of Compound 30 
 
 
Compound 31: tert-butyl N-[2-[[2-(cyclohexylamino)-2-oxo-1-[4-(trifluorom
ethyl)phenyl]ethyl]-(2-furylmethyl)amino]-2-oxo-ethyl]carbamate 
C27H34F3N3O5: White solid; m.p. 183-185C;1H NMR (500MHz,  ppm, CDCl3) 1.00-1.2 (m, 3H), 
1.24-1.42 (m, 2H) 1.44 (s, 9H), 1.54-1.76 (m, 3H), 1.79-1.96 (m, 2H), 3.71-3.86 (m, 1H), 4.21 (s, 
2H), 4.53 (d, J=17.5Hz, 1H), 4.57(d, J=17.5Hz, 1H), 5.42 (s, 1H), 5.77 (s, 1H), 5.93(s, 1H), 6.43 
(m, 2H), 6.13 (s, 1H), 7.21 (s, 1H), phenyl 7.36 (d, J= 8 Hz, 2H), 7.50 (d, J=8 Hz, 2H); 
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 13C NMR; (500MHz, ppm, CDCl3) 24.60, 24.65, 22.29, 28.19, 30.74, 32.56, 42.69, 42.55, 
61.95, 79.60, 108.14, 110.42, 125.21, 129.48, 138.86, 142.01, 149.21, 155.65, 167.40, 170.41; 
IR (Ʋmax cm-1 ATR): 1325,1647,1687, 2935, 3382. Yield 67.7%, 1.457g. 
Note: All spectra for compound 31 can be found on the UsefulChem Wiki Exp235; (Sample ID- 
235-2A); http://usefulchem.wikispaces.com/Exp235 
 
 
 
Figure 7.52 – HNMR of Compound 31 
 152 
 
Figure 7.53 – CNMR of Compound 31 
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Figure 7.54 – HRMS of Compound 31 
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Chapter 8:  Solubility studies 
 
8.1 Introduction 
Our attempts at synthesizing solid Ugi products were not very successful. Usually only one in 
about ten reactions carried out precipitated Ugi products. In several cases it was felt that although 
the product was formed, it still remained dissolved in the solution and either did not precipitate 
out at all or took several days to do so. In order to make the process of synthesizing clean Ugi 
products more efficient, a model which would predict the likelihood of product precipitation was 
planned. The model named the ‘Solubility Model’ was primarily an empirical one based on 
accurate solubility measurements of several starting materials and several Ugi products already 
synthesized in methanol and other solvents used in the Ugi reactions. The computational work 
for developing the model is being performed in collaboration with Prof. Andrew Lang1 and Dr. 
Rajarshi Guha2
8.2 Methods of solution saturation 
.  In order to develop this model several solubility measurements were performed 
in non-aqueous solvents using different methods. This chapter intends to describe those methods. 
Since the main step during solubility assessment involves preparing a saturated solution a few 
methods have been used to ensure saturation of a solution. 
8.2.1 Shake-flask method: The shake-flask method introduced by Higuchi and Connors3 has 
been by far the most widely used method for saturating a solution before solubility assessments. 
The method involves shaking a compound in a solvent of choice for 24 hours or more until no 
more solute can be dissolved in the solvent. A supernatant is then extracted from the solution by 
filtration or by centrifugation or ultracentrifugation and further analyzed for solubility 
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assessment4. This method is also listed as a primary method for solubility assessments in the 
CRC’s “Handbook of solubility of data for pharmaceuticals5
8.2.2 Vortex method: This method was initially used in our lab to prepare saturated solution. 
The method involves dissolving the solute in a solvent by vortexing it over several minutes. The 
method was limited by its reproducibility, since vortexing depended on the researcher, time, and 
temperature of the surrounding and possibly other factors such as the power of the vortex 
machine.  
”. 
8.2.3 Sonication method: An ultra-sound sonicator was used saturate a solution. A solution with 
excess solute was placed in a sonciator for several minutes to saturate it. However, when the 
solution was placed in for an extended period in a sonicator, the temperature of the water bath 
gradually increased as a result of the ultrasonic vibrations. This in turn resulted in inconsistent 
concentrations of the saturated solution.   
8.2.4. Heating-cooling method: In this method a solution with excess solute is heated between 
40-45C (and at least 15C below the boiling point of the solvent) for an hour. The supernatant 
from the solution is quickly decanted in to a clean vials and left at 25C until it precipitates out. In 
this way precipitation is unmistakably noticed and a saturated solution can be obtained in a 
reproducible manner.  
Similar heating-cooling methods have been used in conjunction with other solution saturation 
methods in the literature. In a variation of the shake flask method, equilibration time was 
shortened by heating, which accelerated the process of dissolution of the solid compound 
consequently saturating the solution. Seeding was then induced after cooling to room 
temperature, thus hastening the process of saturation reliably and in a reproducible manner6
 
.  
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8.3   Solubility assessment methods 
In pharmaceutical literature, two types of solubility determinination methods are commonly 
noted the kinetic solubility and the thermodynamic solubility methods. The kinetic solubility 
determination method involves dissolving a solution of a known concentration of a solute in 
DMSO in a dissolution medium at a fixed rate and detect the precipitation process by either 
turbidimetric7 or nephlometric8
During the thermodynamic solubility measurements, concentration of the solution is determined 
when there is an excess solute is present in the solution under a dynamic equilibrium
 methods.  
9
Commonly used solubility assessment techniques include GC, UV-Vis and HPLC methods. 
Calorimetric methods have also been used recently to solubility determination. These methods 
provide higher accuracy than the visual methods.
. 
10 The differential scanning calorimetric (DSC) 
method11
These methods though provide with certain ease and accuracy of the measurements, they not as 
accessible as would desired owing to the expense associated with the methodology and 
instrumentation. Here we describe certain methods which could possibly be used widely without 
the cost impediment associated with solubility methods listed above.  
 has also been used recently for solubility assessments. This method measures 
accurately the changes in the heat content of the system as a function of temperature. Since 
saturation is a dynamic process, DSC can be used to record the equilibrium solubility 
temperature (TE), indicating the complete dissolution of the solid solute. Certain advantages 
using DSC include, low detection limit, computer aided data acquisition and analysis and 
sophisticated heat control. 
8.3.1. Speed-vac method: The speed-vac method appeared to be the most viable method 
compared to contemporary methods used commercially, namely GLC method12. In this method, 
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once a saturated solution was prepared using vortex method, the supernatant was carefully 
decanted in to clean and dry vial. The weight of the aliquots with the vial was carefully 
measured. The vials were then placed in a speed-vac at room temperature.  Vacuum in the 
chamber was also recorded (0.1T). Temperature of the system was maintained between 23-
25C13. The speed-vac was set for a few hours with the vials containing the aliquots in it. The 
vials are then removed from the chamber once the solvent had evaporated. The vials were then 
accurately reweighed and the weight of the solute that was dissolved was calculated. Solubility 
of several aromatic aldehydes was measured14,15,16
A major problem with the speed-vac method was that when the saturated solutions were vacuum 
evaporated the solvent certainly did evaporate; however there was a clear indication that the 
solute had been lost as well. This resulted in erroneous concentration values for the saturated 
solution. This was documented with the aid of pictures take soon after the dry sample vials with 
solute were retrieved from the vacuum chamber. It was later confirmed by repeating the 
experiment
using the speed-vac method. 
17,18
Based on the results, it was decided that the speed-vac method had to be avoided for compounds 
whose boiling points at operating pressure fell below the temperature in the speed-vac chamber.  
. The solubility of 4-chlorobenzaldeyde in chloroform under regular conditions 
(0.1T, 25C and over drying) was initially obtained to be 0.07M. The boiling point of 4-
chlorobenzaldehyde at 0.1T was calculated to be 19C which was below the operation 
temperature. It became clear that the solute had evaporated and the solubility values obtained 
were unusable. The fact was also proven by performing the solubility analysis over a short period 
of time (10min) instead for over night evaporation. Solubility of several solutes with their 
predicted boiling points at 1atm and 0.1T are listed in the figure 8.1.  
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Figure 8.1 Solubility of 4-chlorobenzaldehyde  
 
8.3.2. UV-VIS method 
Maccarone and Perrini’s paper19 published in 1982 described another method for determining 
the solubility. This method was based on UV-VIS technique. The method was rather tedious as 
it involved a few steps before the concentration of the saturated solution could be established. 
The method required a chemist to first determine the molar absorptivity of a dilute solution of 
the compound of interest. Then build a calibration curve and finally perform several dilutions 
of the saturated solution to get absorbance within the measurable range of the instrument. This 
method is widely used to determine the concentration of unknown solutions, especially in non-
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aqueous solvents20
 
. Usually the UV-Vis methods are used in conjunction with the GC, HPLC 
methods for solubility determination. 
  
Figure 8.2: Solubility of vanillin in methanol by speed-vac and UV-VIS methods 
 
Solubility of vanillin in methanol was determined by the UV-VIS method21. Concentration of the 
saturated solution was found to be consistent with the measurements performed using the speed-
vac22,23
The UV-VIS method had a few drawbacks. A major issue was it being a tedious and time 
consuming process, thereby limiting the number of measurements performed. This was mainly 
due to a dual process of calibration for each sample followed by serial dilutions of the saturated 
solution to determine the concentration of the saturated solution. Other issues associated with 
this method included the questionable accuracy of micropipettor with respect to the volatile 
organic solvents with high vapor density in use. Yet another problem was the discrepancy 
between the observed molar absorptivity and one obtained from NIST data base
(Fig 8.4) 
24. These issues 
are exemplified in the UsefulChem experiment 019, where solubility of vanillin was measured25
 
. 
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8.3.3. NMR method and Semi Automated Measurement of Solubility (SAMS) 
Nuclear magnetic spectroscopy has been used to assess the concentration of the saturated 
solutions of organic compounds in non-aqueous solvents and water as well. A small volume of 
the saturated solution (~50-100uL) was carefully and quickly pipetted out in a one dram vial 
containing a deuterated solvent (~ 500-750uL). The solution was then transferred in to a dry 
NMR tube and a proton NMR spectrum of the sample was obtained. The file was saved as a 
JCAMP dx file and uploaded on to server. A detailed instruction for how the process is 
performed has been listed out by Prof. Bradley on his UsefulChem blog26
Once the spectrum is uploaded on to the server, a link to the NMR spectrum in dx format, 
density and molecular weight of the solute and the solvent are incorporated in to a Google 
Spreadsheet. Predicted density of a solid solute is used in place of experimental density. This can 
be obtained from ChemSpider.com. The upper and the lower range of the peaks of interest of the 
solute and the solvent and the number of corresponding hydrogens are incorporated in the 
spreadsheet as well.  The spreadsheet then calculates the molar ratio of the solute to solvent and 
then the concentration of the saturated solution assuming that the volumes of the two 
components are additive. The main advantage of this method is that it avoids all sorts of accurate 
volume measurements. It also does not necessitate a calibration curve, therefore several 
solubility measurements can be performed rapidly. 
. 
In the process of validating the method, an issue with inconsistent integration of proton peaks in 
the spectrum was encountered. It played prominently in the proton spectra of solutes containing 
aromatic protons. In general the aromatic protons and protons on unsaturated carbons under 
integrated compared to the protons on methyl and methylene carbons. The problem was resolved 
by using extended relaxation delay (d1) of 50 s.   
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Proton NMR spectra of a solution of 1-pyrenebutyric acid in THF, obtained using different 
relaxation delay-d1 (a) default setting d1=0.3s and (b) d1=50s, were compared to check how the 
peak integrations for aromatic region (7.84-8.415 ppm) measured to that of a selected methylene 
peak (2.34- 2.44 ppm) . Difference in percent integration per proton was calculated. Results are 
summarized in the table below (Table 8.2) 27
 
Relaxation delay d1 
. 
0.3 s 50 s 
Full aromatic (9H) vs. methylene 16.83 -0.79 
One aromatic H (7.84-8.415ppm) vs. methylene 8.71 0.05 
One aromatic H (8.07 8.132ppm) vs. methylene 18.38 -0.07 
One aromatic H (7.894 7.94ppm) vs. methylene 15.87 1.22 
 
Table 8.1 Percent difference in the Peak Integration of 1-pyrenebutyric acid in THF using 0.3 s 
and 50 s relaxation delays (d1) 
Increasing the relaxation delay d1 from 0.3s to 50s resulted in uniform peak integrations per 
proton over the entire spectrum. Comparison of the integration pattern of the spectra is provided 
in Fig 8.5.  
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8.3.3.1 Hemiacetal formation   
Some aldehydes, like 4-nitrobenzaldehyde, 2-chloro-5-nitrobenzaldehyde, 2,6-
dichlorobenzaldehyde and similar compounds with electron withdrawing groups on the aromatic 
rings form hemiacetals upon interaction with alcoholic solvents. This was observed when 4-
nitrobenzaldehyde was dissolved in methanol28
 
  (Fig 8.2).  
 
 
 
Figure 8.4: Hemiacetal of 4-nitrobenzaldehyde in methanol (3:1 aldehyde: hemiacetal ratio) 
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Figure 8.5: 2-chloro-5-nitrobenzaldehyde in methanol (2:3 aldehyde: hemiacetal ratio) 
 
Similar results were seen for 2-chloro-5-nitrobenzaldehyde in methanol and ethanol29
SAMS not only provided a reliable method for solubility determination, it also provided a clear 
understanding of the discrepant solubility of the solutes which reacted with the solvents  
.  In the 
case of 2-chloro-5-nitrobenzaldehyde where there is an additional electron withdrawing group on 
the ring, the hemiacetal formation was more pronounced, with the aldehyde form accounting to 
only 40% of the mixture in methanol (Fig 8.3). 
8.4 Solubility of liquid solutes 
All liquids were completely miscible with the solvents used. None of the liquid solutes 
developed any partitioning with the solvents; therefore solubility was determined based on their 
densities. For example solubility of 2-furaldehyde in methanol was calculated based on its 
density.  
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Aldehyde 
Density 
(g/mL) 
Density 
(g/Liter) 
Molecular 
weight 
(g/mole) 
Concentration of 
the solution (M) 
 
2-furaldehyde 1.15482 1154.82 96.0841 12.02 
 
Table 8.2 Determination of the solubility of a liquid solute from its density 
 
Table 8.3:  Measured solubility of several Ugi reaction starting materials and products. 
Si# Exp Ref 
From ONS  
wiki 
solute solvent concentratio
n (M) 
1 Exp071 veratraldehyde acetonitrile 5.940 
2 Exp071 veratraldehyde chloroform 5.960 
3 Exp071 veratraldehyde dichloromethane 6.060 
4 Exp071 veratraldehyde diethyl ether 3.550 
5 Exp071 veratraldehyde DMSO 5.310 
6 Exp071 veratraldehyde ethanol 5.430 
7 Exp071 veratraldehyde hexane 0.070 
8 Exp071 veratraldehyde methanol 5.870 
9 Exp071 veratraldehyde THF 5.670 
10 Exp071 veratraldehyde toluene 5.110 
11 UCExp208 veratraldehyde acetonitrile 5.570 
12 UCExp208 veratraldehyde chloroform 5.440 
13 UCExp208 veratraldehyde ethanol 5.550 
14 UCExp208 veratraldehyde THF 5.000 
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15 UCExp208 veratraldehyde toluene 3.960 
16 Exp019 vanillin methanol 4.140 
17 Exp065 Ugi product 86B (UC) methanol 0.170 
18 Exp065 Ugi product 64C (UC) methanol 0.030 
19 Exp065 Ugi product 62E (UC) methanol 0.130 
20 Exp071 Ugi product 215F(UC) acetonitrile 0.040 
21 Exp071 Ugi product 215F(UC) DMSO 0.380 
22 Exp071 Ugi product 215F(UC) ethanol 0.060 
23 Exp071 Ugi product 215F(UC) methanol 0.120 
24 Exp071 Ugi product 215F(UC) THF 0.610 
25 Exp071 Ugi product 215F(UC) toluene 0.070 
26 Exp027 Ugi product 214C(UC) methanol 0.007 
27 Exp027 Ugi product 214C(UC) THF 0.352 
28 Exp056 Ugi product 206B(UC) 2-propanol 0.000 
29 Exp056 Ugi product 206B(UC) acetonitrile 0.022 
30 Exp056 Ugi product 206B(UC) benzene 0.006 
31 Exp056 Ugi product 206B(UC) carbon 
tetrachloride 
0.003 
32 Exp056 Ugi product 206B(UC) chloroform 0.567 
33 Exp056 Ugi product 206B(UC) cyclohexane 0.000 
34 Exp056 Ugi product 206B(UC) cyclopentane 0.000 
35 Exp056 Ugi product 206B(UC) dichloromethane 0.238 
36 Exp056 Ugi product 206B(UC) diethyl ether 0.000 
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37 Exp056 Ugi product 206B(UC) DMF 0.239 
38 Exp056 Ugi product 206B(UC) DMSO 0.229 
39 Exp056 Ugi product 206B(UC) ethanol 0.017 
40 Exp056 Ugi product 206B(UC) hexane 0.000 
41 Exp056 Ugi product 206B(UC) methanol 0.046 
42 Exp056 Ugi product 206B(UC) THF 0.258 
43 Exp056 Ugi product 206B(UC) toluene 0.010 
44 Exp127 Ugi product 176C (UC) 1,4-dioxane 0.190 
45 Exp127 Ugi product 176C (UC) acetonitrile 0.020 
46 Exp127 Ugi product 176C (UC) benzene 0.030 
47 Exp127 Ugi product 176C (UC) diethyl ether 0.020 
48 Exp127 Ugi product 176C (UC) DMF 0.270 
49 Exp127 Ugi product 176C (UC) DMSO 0.190 
50 Exp127 Ugi product 176C (UC) ethanol 0.010 
51 Exp127 Ugi product 176C (UC) methanol 0.020 
52 Exp127 Ugi product 176C (UC) THF 0.280 
53 Exp127 Ugi product 176C (UC) toluene 0.030 
54 Exp144 Ugi product 176C (UC) benzene 0.030 
55 Exp144 Ugi product 176C (UC) benzene 0.030 
56 Exp155 Ugi product 176C (UC) 1-octanol 0.010 
57 Exp155 Ugi product 176C (UC) 1-octanol 0.010 
58 Exp165 Ugi product 176C (UC) ethyl acetate 0.010 
59 Exp065 Ugi product 173G (UC) methanol 0.180 
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60 Exp065 Ugi product 173B (UC) methanol 0.080 
61 Exp065 Ugi product 171K (UC) methanol 0.020 
62 Exp065 Ugi product 150D(UC) methanol 0.070 
63 Exp078 Ugi product 150D(UC) acetonitrile 0.040 
64 Exp078 Ugi product 150D(UC) DMSO 0.180 
65 Exp078 Ugi product 150D(UC) ethanol 0.040 
66 Exp078 Ugi product 150D(UC) methanol 0.060 
67 Exp078 Ugi product 150D(UC) THF 0.490 
68 Exp078 Ugi product 150D(UC) toluene 0.040 
69 Exp145 Ugi product 148B acetonitrile 0.020 
70 Exp145 Ugi product 148B acetonitrile 0.020 
71 Exp145 Ugi product 148B benzene 0.050 
72 Exp145 Ugi product 148B benzene 0.050 
73 Exp145 Ugi product 148B ethanol 0.000 
74 Exp145 Ugi product 148B ethanol 0.000 
75 Exp145 Ugi product 148B methanol 0.030 
76 Exp145 Ugi product 148B methanol 0.030 
77 Exp145 Ugi product 148B THF 0.390 
78 Exp145 Ugi product 148B THF 0.400 
79 Exp065 Ugi product 109C(UC) methanol 0.150 
80 Exp065 Ugi product 108C (UC) methanol 0.360 
81 Exp065 Ugi product 104C (UC) methanol 0.290 
82 Exp113 UCExp216-3A acetonitrile 0.040 
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83 Exp113 UCExp216-3A DMSO 0.280 
84 Exp113 UCExp216-3A ethanol 0.030 
85 Exp113 UCExp216-3A methanol 0.060 
86 Exp113 UCExp216-3A toluene 0.010 
87 Exp022 trichloroacetic acid methanol 9.910 
88 Exp022 trans-2-hexen-1-al methanol 8.620 
89 Exp138 salicylic acid dichloromethane 0.150 
90 Exp138 salicylic acid toluene 0.110 
91 Exp021 salicylaldehyde methanol 10.040 
92 Exp109 pyrene acetonitrile 0.163 
93 Exp022 propanoic acid methanol 13.410 
94 Exp030 piperonal methanol 7.470 
95 Exp071 piperonal acetonitrile 7.110 
96 Exp071 piperonal chloroform 7.950 
97 Exp071 piperonal dichloromethane 7.590 
98 Exp071 piperonal diethyl ether 6.380 
99 Exp071 piperonal DMSO 6.050 
100 Exp071 piperonal ethanol 4.990 
101 Exp071 piperonal hexane 0.150 
102 Exp071 piperonal methanol 7.100 
103 Exp071 piperonal THF 7.440 
104 Exp071 piperonal toluene 6.400 
105 Exp138 phthalic acid chloroform 0.510 
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106 Exp086 phenylacetic acid acetonitrile 3.870 
107 Exp086 phenylacetic acid toluene 1.940 
108 Exp165 phenylacetic acid ethyl acetate 3.980 
109 Exp024 phenanthrene-9-carboxaldehyde methanol 0.078 
 
 
 
110 Exp030 phenanthrene-9-carboxaldehyde 1,1,2-
trichlorotrifluoreth
ane 
0.020 
111 Exp051 phenanthrene-9-carboxaldehyde DMSO 0.890 
112 Exp060 phenanthrene-9-carboxaldehyde 2-propanol 0.070 
113 Exp060 phenanthrene-9-carboxaldehyde acetonitrile 0.090 
114 Exp060 phenanthrene-9-carboxaldehyde chloroform 0.040 
115 Exp060 phenanthrene-9-carboxaldehyde cyclohexane 0.070 
116 Exp060 phenanthrene-9-carboxaldehyde cyclopentane 0.030 
117 Exp060 phenanthrene-9-carboxaldehyde dichloromethane 0.000 
118 Exp060 phenanthrene-9-carboxaldehyde diethyl ether 0.100 
119 Exp060 phenanthrene-9-carboxaldehyde DMF 1.250 
120 Exp060 phenanthrene-9-carboxaldehyde DMSO 0.650 
121 Exp060 phenanthrene-9-carboxaldehyde ethanol 0.100 
122 Exp060 phenanthrene-9-carboxaldehyde hexane 0.070 
123 Exp060 phenanthrene-9-carboxaldehyde methanol 0.130 
124 Exp060 phenanthrene-9-carboxaldehyde toluene 0.140 
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125 Exp136 phenanthrene-9-carboxaldehyde acetonitrile 0.150 
126 Exp165 phenanthrene-9-carboxaldehyde ethyl acetate 0.440 
127 Exp167 phenanthrene-9-carboxaldehyde THF 1.290 
128 UCExp242 phenanthrene-9-carboxaldehyde benzene 0.660 
129 Exp022 pentanoic acid methanol 9.190 
130 UCExp208 p-toluenesulfonylmethyl isocyanide acetonitrile 1.880 
131 UCExp208 p-toluenesulfonylmethyl isocyanide chloroform 0.210 
132 UCExp208 p-toluenesulfonylmethyl isocyanide ethanol 0.180 
133 UCExp208 p-toluenesulfonylmethyl isocyanide THF 1.860 
134 UCExp208 p-toluenesulfonylmethyl isocyanide toluene 0.140 
135 Exp136 p-toluenesulfonic acid ethanol 4.690 
136 Exp021 p-tolualdehyde methanol 8.470 
137 Exp021 p-tolualdehyde methanol 8.470 
138 Exp021 p-anisaldehyde methanol 8.220 
139 Exp022 octanoic acid methanol 6.310 
140 UCExp207 o-vanillin methanol 2.270 
141 UCExp208 o-vanillin acetonitrile 2.560 
142 UCExp208 o-vanillin ethanol 3.040 
143 UCExp208 o-vanillin THF 5.370 
144 UCExp208 o-vanillin toluene 3.820 
145 Exp137 nicotinic acid acetonitrile 0.000 
146 Exp137 nicotinic acid benzene 0.000 
147 Exp137 nicotinic acid ethanol 0.090 
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148 Exp137 nicotinic acid methanol 0.060 
149 Exp137 nicotinic acid THF 0.090 
150 Exp134 N-Cbz-L-proline methanol 4.260 
151 Exp022 methoxyacetic acid methanol 13.030 
152 Exp022 methacrylic acid methanol 11.790 
153 Exp071 mandelic acid chloroform 0.120 
154 Exp021 m-anisaldehyde methanol 8.200 
155 Exp022 linoleic acid methanol 3.220 
156 Exp022 isovaleric acid methanol 9.060 
157 Exp022 hexanoic acid methanol 7.980 
158 Exp021 hexanaldehyde methanol 8.330 
159 Exp020 furfuraldehyde methanol 12.020 
160 Exp022 formic acid methanol 26.500 
161 Exp077 diphenylacetic acid methanol 1.360 
162 Exp081 diphenylacetic acid acetonitrile 0.460 
163 Exp081 diphenylacetic acid DMSO 2.560 
164 Exp081 diphenylacetic acid ethanol 1.150 
165 Exp081 diphenylacetic acid methanol 1.180 
166 Exp081 diphenylacetic acid THF 2.910 
167 Exp081 diphenylacetic acid toluene 0.170 
168 Exp022 cyclohexanepropionic acid methanol 5.840 
169 Exp022 cyclohexanecarboxylic acid methanol 8.060 
170 Exp021 cyclohexanecarbaldehyde methanol 8.290 
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171 Exp062 crotonic acid benzene 4.450 
172 Exp062 crotonic acid ethanol 6.150 
173 Exp062 crotonic acid methanol 7.620 
174 Exp062 crotonic acid THF 8.090 
175 Exp062 crotonic acid toluene 3.520 
176 Exp064 crotonic acid acetonitrile 3.590 
177 Exp064 crotonic acid chloroform 6.880 
178 Exp064 crotonic acid chloroform 7.540 
179 Exp064 crotonic acid chloroform 7.600 
180 Exp064 crotonic acid DMSO 7.760 
181 Exp064 crotonic acid hexane 1.070 
182 Exp021 crotonaldehyde methanol 12.170 
183 Exp022 butyric acid methanol 10.940 
184 Exp071 boc-glycine acetonitrile 2.460 
185 Exp071 boc-glycine chloroform 3.850 
186 Exp071 boc-glycine dichloromethane 4.140 
187 Exp071 boc-glycine diethyl ether 2.650 
188 Exp071 boc-glycine DMSO 4.780 
189 Exp071 boc-glycine ethanol 4.650 
190 Exp071 boc-glycine hexane 0.250 
191 Exp071 boc-glycine methanol 5.050 
192 Exp071 boc-glycine THF 4.770 
193 Exp071 boc-glycine toluene 0.190 
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194 Exp133 boc-glycine THF 3.184 
195 Exp133 boc-glycine THF 3.809 
196 Exp135 boc-glycine THF 2.936 
197 Exp135 boc-glycine THF 3.385 
198 Exp135 boc-glycine THF 3.631 
199 Exp135 boc-glycine THF 3.799 
200 Exp135 boc-glycine THF 3.990 
201 Exp135 boc-glycine THF 4.165 
202 Exp143 boc-glycine 2-propanol 3.580 
203 Exp143 boc-glycine 2-propanol 3.670 
204 Exp143 boc-glycine benzene 0.220 
205 Exp143 boc-glycine benzene 0.290 
206 Exp136 benzoic acid methanol 2.970 
207 Exp155 benzoic acid 1-octanol 1.480 
208 Exp155 benzoic acid 1-octanol 1.490 
209 Exp021 benzaldehyde methanol 9.850 
210 Exp136 B,B-dimethylacrylic acid methanol 4.730 
211 Exp022 acetylsalicylic acid methanol 1.300 
212 Exp022 acetic acid methanol 17.470 
213 Exp021 5-bromothiophene-2-carbaldehyde methanol 9.220 
214 Exp024 4-pyrenebutanoic acid methanol 0.022 
215 Exp029 4-pyrenebutanoic acid methanol 0.000 
216 Exp051 4-pyrenebutanoic acid DMSO 1.910 
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217 Exp061 4-pyrenebutanoic acid 2-propanol 0.060 
218 Exp061 4-pyrenebutanoic acid acetonitrile 0.000 
219 Exp061 4-pyrenebutanoic acid benzene 0.000 
220 Exp061 4-pyrenebutanoic acid carbon 
tetrachloride 
0.000 
221 Exp061 4-pyrenebutanoic acid chloroform 0.030 
222 Exp061 4-pyrenebutanoic acid cyclohexane 0.000 
223 Exp061 4-pyrenebutanoic acid cyclopentane 0.000 
224 Exp061 4-pyrenebutanoic acid dichloromethane 0.070 
225 Exp061 4-pyrenebutanoic acid diethyl ether 0.020 
226 Exp061 4-pyrenebutanoic acid DMF 1.900 
227 Exp061 4-pyrenebutanoic acid DMSO 2.130 
228 Exp061 4-pyrenebutanoic acid ethanol 0.060 
229 Exp061 4-pyrenebutanoic acid hexane 0.000 
230 Exp061 4-pyrenebutanoic acid methanol 0.020 
231 Exp061 4-pyrenebutanoic acid toluene 0.000 
232 Exp084 4-pyrenebutanoic acid THF 0.550 
233 Exp033 4-nitrobenzaldehyde methanol -0.100 
234 UCExp205 4-nitrobenzaldehyde methanol -0.100 
235 Exp212 4-nitrobenzaldehyde acetonitrile 1.060 
236 Exp136 4-methoxyphenylacetic acid methanol 2.570 
237 UCExp205 4-hydroxybenzaldehyde methanol 3.280 
238 UCExp208 4-hydroxybenzaldehyde acetonitrile 1.460 
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239 UCExp208 4-hydroxybenzaldehyde chloroform 1.750 
240 UCExp208 4-hydroxybenzaldehyde ethanol 2.650 
241 UCExp208 4-hydroxybenzaldehyde THF 3.510 
242 UCExp208 4-hydroxybenzaldehyde toluene 0.020 
243 Exp033 4-dimethylaminobenzaldehyde methanol 1.360 
244 UCExp208 4-dimethylaminobenzaldehyde acetonitrile 2.600 
245 UCExp208 4-dimethylaminobenzaldehyde chloroform 4.020 
246 UCExp208 4-dimethylaminobenzaldehyde ethanol 0.630 
247 UCExp208 4-dimethylaminobenzaldehyde THF 2.500 
248 UCExp208 4-dimethylaminobenzaldehyde toluene 1.540 
249 Exp073 4-chlorophenylacetic acid methanol 7.440 
250 Exp073 4-chlorophenylacetic acid methanol 8.070 
251 Exp073 4-chlorophenylacetic acid THF 4.100 
252 Exp073 4-chlorophenylacetic acid THF 4.240 
253 Exp075 4-chlorophenylacetic acid acetonitrile 2.410 
254 Exp075 4-chlorophenylacetic acid DMSO 5.740 
255 Exp075 4-chlorophenylacetic acid THF 5.020 
256 Exp075 4-chlorophenylacetic acid toluene 0.890 
257 Exp007 4-chlorobenzaldehyde acetonitrile 5.545 
258 Exp033 4-chlorobenzaldehyde methanol 3.550 
259 UCExp209 4-chlorobenzaldehyde chloroform 3.600 
260 UCExp209 4-chlorobenzaldehyde chloroform 3.620 
261 Exp137 4-acetamidobenzoic acid acetonitrile 0.010 
 
 
182 
262 Exp137 4-acetamidobenzoic acid benzene 0.000 
263 Exp137 4-acetamidobenzoic acid ethanol 0.230 
264 Exp137 4-acetamidobenzoic acid methanol 0.190 
265 Exp137 4-acetamidobenzoic acid THF 0.170 
266 Exp021 4-(trifluoromethyl)benzaldehyde methanol 7.320 
267 UCExp205 3,5-dimethoxybenzaldehyde methanol 1.710 
268 UCExp208 3,5-dimethoxybenzaldehyde THF 4.030 
269 Exp131 3,4methylendioxyphenylacec acid THF 1.950 
270 Exp132 3,4-methylendioxyphenylacetic acid methanol 1.000 
271 Exp138 3,4-(methylenedioxy)phenylacetic acid acetonitrile 0.100 
272 Exp022 3-mercaptopropionic acid methanol 11.480 
273 Exp033 2,6-dichlorobenzaldehyde methanol -0.100 
274 UCExp205 2,6-dichlorobenzaldehyde methanol -0.100 
275 UCExp208 2,6-dichlorobenzaldehyde acetonitrile 1.350 
276 UCExp208 2,6-dichlorobenzaldehyde chloroform 3.410 
277 UCExp208 2,6-dichlorobenzaldehyde ethanol -0.100 
278 UCExp208 2,6-dichlorobenzaldehyde THF 2.480 
279 UCExp208 2,6-dichlorobenzaldehyde toluene 1.740 
280 Exp021 2,4-dimethylbenzaldehyde methanol 7.170 
281 Exp021 2,2-diphenylacetaldehyde methanol 5.640 
282 Exp021 2-phenylpropanal methanol 7.530 
283 Exp079 2-phenylbutyric acid acetonitrile 6.180 
284 Exp079 2-phenylbutyric acid ethanol 6.200 
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285 Exp083 2-phenylbutyric acid DMSO 5.970 
286 Exp083 2-phenylbutyric acid THF 5.960 
287 Exp083 2-phenylbutyric acid toluene 5.350 
288 Exp022 2-octenoic acid methanol 6.640 
289 Exp022 2-methyl butyric acid methanol 9.160 
290 UCExp205 2-methoxy-1-naphthaldehyde methanol 1.260 
291 Exp022 2-ethylhexanoic acid methanol 6.260 
292 Exp022 2-ethylbutyraldehyde methanol 8.130 
293 Exp033 2-chloro-5-nitrobenzaldehyde methanol -0.100 
294 vExp208 2-chloro-5-nitrobenzaldehyde acetonitrile 3.120 
295 cExp208 2-chloro-5-nitrobenzaldehyde chloroform 2.900 
296 UCExp208 2-chloro-5-nitrobenzaldehyde ethanol -0.100 
297 UCExp208 2-chloro-5-nitrobenzaldehyde THF 2.830 
298 UCExp208 2-chloro-5-nitrobenzaldehyde toluene 2.000 
 
Once the solubility of the reactants and the Ugi products were determined, a model based on 
‘Random Forest30’and Abrahams solubility parameters31,32 was built by Prof. Andrew Lang 
(collaborator) 33. The model predicts the solubility of organic solutes in different solvents using 
only open molecular descriptors, mainly relying on the CDK (Chemistry Development Kit), an 
open source project resource34
8.5 Conclusions 
. 
Solubility of organic compounds on non-aqueous solvents has been determined using different 
method, including the speed-vac method, the UV-VIS method and the NMR method. The NMR 
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method was found to be more efficient and reliable when the relaxation delay between the pulse 
sequences was increase to 50s. Liquid solutes (used in the Ugi reaction) were found to be 
completely miscible in the solvents for the Ugi reaction, specifically methanol and THF, 
therefore solubility was calculated based on their densities.  
Solubility prediction models have been built using the data obtained from the measurements by 
our collaborators. These models use openly source data in order to predict the solubility.  
Contributions: Solubility modeling studies was performed by Prof. Andrew Lang, Dr. Rajarshi 
Guha and Prof. Jean-Claude Bradley. Experimental solubility assessment was performed by 
Khalid Mirza, Marshall Moritz, Tim Bohinshky, David Bulger, Sozit Kurtu, Jenna Mancinelli, 
Matthew Federici, Jennifer Hale, Daniel Rein, Cedric Tchakounte, Hai Truong, Brent Freisen. 
Details of the results of this collaborative effort was published in a book form available at 
lulu.com (http://usefulchem.blogspot.com/2010/02/ons-solubility-book-edition-3-with.html) 
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